<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="cns70367" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">CNS Neurosci Ther</journal-id><journal-id journal-id-type="iso-abbrev">CNS Neurosci Ther</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1755-5949</journal-id><journal-id journal-id-type="publisher-id">CNS</journal-id><journal-title-group><journal-title>CNS Neuroscience &#x00026; Therapeutics</journal-title></journal-title-group><issn pub-type="ppub">1755-5930</issn><issn pub-type="epub">1755-5949</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40406932</article-id><article-id pub-id-type="pmc">PMC12099305</article-id><article-id pub-id-type="doi">10.1111/cns.70367</article-id><article-id pub-id-type="publisher-id">CNS70367</article-id><article-id pub-id-type="other">CNSNT-2024-2430.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Ligustrazine Alleviates Blood&#x02013;Brain Barrier Damage by Downregulating Expression of <styled-content style="fixed-case" toggle="no">miR</styled-content>&#x02010;297c&#x02010;5p</article-title></title-group><contrib-group><contrib id="cns70367-cr-0001" contrib-type="author"><name><surname>Guan</surname><given-names>Shaoyu</given-names></name><xref rid="cns70367-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cns70367-cr-0002" contrib-type="author"><name><surname>Jiang</surname><given-names>Ruichen</given-names></name><xref rid="cns70367-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cns70367-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cns70367-cr-0003" contrib-type="author"><name><surname>Wang</surname><given-names>Xudong</given-names></name><xref rid="cns70367-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="cns70367-cr-0004" contrib-type="author"><name><surname>Chen</surname><given-names>Tong</given-names></name><xref rid="cns70367-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="cns70367-cr-0005" contrib-type="author"><name><surname>Yi</surname><given-names>Ping</given-names></name><xref rid="cns70367-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cns70367-cr-0006" contrib-type="author" corresp="yes"><name><surname>Li</surname><given-names>Tian</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8281-4459</contrib-id><xref rid="cns70367-aff-0006" ref-type="aff">
<sup>6</sup>
</xref><address><email>fmmult@foxmail.com</email></address></contrib><contrib id="cns70367-cr-0007" contrib-type="author" corresp="yes"><name><surname>Ma</surname><given-names>Teng</given-names></name><xref rid="cns70367-aff-0007" ref-type="aff">
<sup>7</sup>
</xref><address><email>mateng1023@163.com</email></address></contrib><contrib id="cns70367-cr-0008" contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Fang</given-names></name><xref rid="cns70367-aff-0008" ref-type="aff">
<sup>8</sup>
</xref><address><email>xiaoxiao_8236@sina.com</email></address></contrib></contrib-group><aff id="cns70367-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Pharmaceutical Sciences Research Division, Department of Pharmacy</named-content>
<institution>Medical Supplies Centre of PLA General Hospital/Medical School of Chinese PLA</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="cns70367-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Clinical Medicine</named-content>
<institution>Beijing University of Chinese Medicine</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="cns70367-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Orthopaedics</named-content>
<institution>China&#x02010;Japan Friendship Hospital</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="cns70367-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Dermatology</named-content>
<institution>The Seventh Medical Center of Chinese PLA General Hospital/Medical School of Chinese PLA</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="cns70367-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Cardiology</named-content>
<institution>The Sixth Medical Centre, Chinese PLA General Hospital/Medical School of Chinese PLA</institution>
<city>Beijing</city>
<country country="CN">China</country>
</aff><aff id="cns70367-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Tianjin Key Laboratory of Acute Abdomen Disease&#x02010;Associated Organ Injury and ITCWM Repair, Institute of Integrative Medicine of Acute Abdominal Diseases</named-content>
<institution>Tianjin Nankai Hospital, Tianjin Medical University</institution>
<city>Tianjin</city>
<country country="CN">China</country>
</aff><aff id="cns70367-aff-0007">
<label>
<sup>7</sup>
</label>
<named-content content-type="organisation-division">Department of Trauma Orthopedics</named-content>
<institution>General Hospital of Ningxia Medical University</institution>
<city>Yinchuan</city>
<country country="CN">China</country>
</aff><aff id="cns70367-aff-0008">
<label>
<sup>8</sup>
</label>
<institution>Medical Imaging Center of People's Hospital of Ningxia Hui Autonomous Region/Ningxia Medical University</institution>
<city>Yinchuan</city>
<country country="CN">China</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Tian Li (<email>fmmult@foxmail.com</email>)<break/>
Teng Ma (<email>mateng1023@163.com</email>)<break/>
Fang Wang (<email>xiaoxiao_8236@sina.com</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2025</year></pub-date><volume>31</volume><issue seq="80">5</issue><issue-id pub-id-type="doi">10.1111/cns.v31.5</issue-id><elocation-id>e70367</elocation-id><history>
<date date-type="rev-recd"><day>08</day><month>2</month><year>2025</year></date>
<date date-type="received"><day>19</day><month>11</month><year>2024</year></date>
<date date-type="accepted"><day>28</day><month>2</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">CNS Neuroscience &#x00026; Therapeutics</italic> published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:CNS-31-e70367.pdf"/><abstract><title>ABSTRACT</title><sec id="cns70367-sec-0001"><title>Objective</title><p>Ligustrazine (LSZ), an ingredient of <italic toggle="no">Ligusticum chuanxiong</italic>, has long been used to treat neurovascular diseases in China. This study investigates its protective effects for the impairment of the blood&#x02013;brain barrier (BBB) and the underlying mechanisms.</p></sec><sec id="cns70367-sec-0002"><title>Methods</title><p>In this study, the impacts of LSZ on the BBB function were firstly assessed in b. End3 cells in&#x000a0;vitro. Oxygen&#x02013;glucose deprivation (OGD) served as an injury factor and western blot (WB) analyzed the expressions of occludin and ZO&#x02010;1, two tight junction proteins (TJs), essential for maintaining the integrity of the BBB. After bioinformatics analysis of the transcriptome in&#x000a0;vivo, qRT&#x02010;PCR of miR&#x02010;297c&#x02010;5p was conducted and a dual&#x02010;luciferase reporter assay was used to verify the target protein, occludin, which was confirmed by hippocampal insertion using guide cannulas and microinfection of RNA oligos.</p></sec><sec id="cns70367-sec-0003"><title>Results</title><p>A 3&#x02010;h deprivation of OGD of b. End3 cells resulted in noticeable reductions in the level of occludin and ZO&#x02010;1. However, administration of LSZ (0.1&#x02009;&#x003bc;M) effectively restored these decreases. In normal mice, administration of LSZ (25&#x02009;mg/kg, i.p., once daily for 9&#x02009;days) resulted in a notable reduction in miR&#x02010;297c&#x02010;5p. In the middle cerebral artery occlusion (MCAO) mouse model, increased miR&#x02010;297c&#x02010;5p was also reversed by LSZ administration. Bioinformatics analysis revealed one of the targets of miR&#x02010;297c&#x02010;5p includes occludin. MiR&#x02010;297c&#x02010;5p was found to directly target occludin in the dual&#x02010;luciferase reporter assay. Transfection of miR&#x02010;297c&#x02010;5p agomir into b. End3 cells resulted in a significant reduction in the level of occludin, while transfection of antagomir led to an increase in occludin. Besides, stereotaxic injection of AAV&#x02010;miR&#x02010;297c&#x02010;5p into the hippocampus reduced occludin level in&#x000a0;vivo. Ultimately, hippocampal microinfection of RNA oligos provided a confirmation that miR&#x02010;297c&#x02010;5p was downregulated by LSZ in MCAO mice with up&#x02010;regulated occludin expression.</p></sec><sec id="cns70367-sec-0004"><title>Conclusion</title><p>In conclusion, the present findings provide new insights into regulating occludin by LSZ through downregulation of miR&#x02010;297c&#x02010;5p.</p></sec></abstract><abstract abstract-type="graphical"><p>The potential role of ligustrazine (LSZ) in downregulating miR&#x02010;297c&#x02010;5p, which targets one of the tight junction proteins, occludin, following ischemic injury in mice and oxygen&#x02013;glucose deprivation (OGD) in b. End3 cells.<boxed-text position="anchor" content-type="graphic" id="cns70367-blkfxd-0001"><graphic xlink:href="CNS-31-e70367-g002.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="cns70367-kwd-0001">blood&#x02013;brain barrier</kwd><kwd id="cns70367-kwd-0002">ligustrazine</kwd><kwd id="cns70367-kwd-0003">miR&#x02010;297c&#x02010;5p</kwd><kwd id="cns70367-kwd-0004">tight junction</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>2022 Ningxia Hui Autonomous Region Natural Science Foundation (General) Project</funding-source><award-id>2022AAC03390</award-id></award-group></funding-group><counts><fig-count count="8"/><table-count count="2"/><page-count count="13"/><word-count count="8200"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:23.05.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="cns70367-ntgp-0001"><fn fn-type="equal" id="cns70367-note-0001"><p>Shaoyu Guan, Ruichen Jiang and Xudong Wang are equal contribution to this work.</p></fn><fn fn-type="funding" id="cns70367-note-0002"><p>
<bold>Funding:</bold> Ningxia Hui Autonomous Region Natural Science Foundation (General) Project number : 2022AAC03390.</p></fn></fn-group></notes></front><body id="cns70367-body-0001"><def-list list-content="abbreviations" id="cns70367-dl-0001"><title>Abbreviations</title><def-item><term id="cns70367-li-0001">AAV</term><def id="cns70367-li-0002"><p>adeno&#x02010;associated virus</p></def></def-item><def-item><term id="cns70367-li-0003">BBB</term><def id="cns70367-li-0004"><p>blood&#x02013;brain barrier</p></def></def-item><def-item><term id="cns70367-li-0005">BMECs</term><def id="cns70367-li-0006"><p>brain microvascular endothelial cells</p></def></def-item><def-item><term id="cns70367-li-0007">CNS</term><def id="cns70367-li-0008"><p>central nervous system</p></def></def-item><def-item><term id="cns70367-li-0009">ELISA</term><def id="cns70367-li-0010"><p>Enzyme linked immunosorbent assay</p></def></def-item><def-item><term id="cns70367-li-0011">GFP</term><def id="cns70367-li-0012"><p>green fluorescent protein</p></def></def-item><def-item><term id="cns70367-li-0013">KEGG</term><def id="cns70367-li-0014"><p>Kyoto Encyclopedia of Genes and Genomes</p></def></def-item><def-item><term id="cns70367-li-0015">LPS</term><def id="cns70367-li-0016"><p>lipopolysaccharides</p></def></def-item><def-item><term id="cns70367-li-0017">LSD</term><def id="cns70367-li-0018"><p>least significant difference</p></def></def-item><def-item><term id="cns70367-li-0019">LSZ</term><def id="cns70367-li-0020"><p>ligustrazine</p></def></def-item><def-item><term id="cns70367-li-0021">MCAO</term><def id="cns70367-li-0022"><p>middle cerebral artery occlusion</p></def></def-item><def-item><term id="cns70367-li-0023">miRNA</term><def id="cns70367-li-0024"><p>microRNA</p></def></def-item><def-item><term id="cns70367-li-0025">NC</term><def id="cns70367-li-0026"><p>negative control</p></def></def-item><def-item><term id="cns70367-li-0027">OGD</term><def id="cns70367-li-0028"><p>oxygen&#x02013;glucose deprivation</p></def></def-item><def-item><term id="cns70367-li-0029">qRT&#x02010;PCR</term><def id="cns70367-li-0030"><p>quantitative real&#x02010;time PCR</p></def></def-item><def-item><term id="cns70367-li-0031">RIN</term><def id="cns70367-li-0032"><p>RNA integrity number</p></def></def-item><def-item><term id="cns70367-li-0033">TJs</term><def id="cns70367-li-0034"><p>tight junction proteins</p></def></def-item></def-list><sec id="cns70367-sec-0005"><label>1</label><title>Introduction</title><p>Composed of astrocytes, pericytes, and endothelial cells, the blood&#x02013;brain barrier (BBB) is a highly specialized structure that controls the movement of substances from peripheral fluids into the central nervous system (CNS) [<xref rid="cns70367-bib-0001" ref-type="bibr">1</xref>]. Endothelium, serving as the initial barrier between the blood and brain, is upheld by tight junction proteins (TJs), including occludin, ZO&#x02010;1, and claudin&#x02010;5, which exist between adjacent endothelial cells [<xref rid="cns70367-bib-0002" ref-type="bibr">2</xref>, <xref rid="cns70367-bib-0003" ref-type="bibr">3</xref>]. Caveolins, specific transport vesicles in the plasma membrane, perform transcytosis in the BBB under physiological conditions [<xref rid="cns70367-bib-0004" ref-type="bibr">4</xref>]. Cerebral insult may influence TJs distribution as well as caveolins activation [<xref rid="cns70367-bib-0005" ref-type="bibr">5</xref>]. Thus, exotics may pass through the BBB and induce neurotoxicity and functional impairment in the brain [<xref rid="cns70367-bib-0006" ref-type="bibr">6</xref>].</p><p>Ligustrazine (LSZ) is a potent component of <italic toggle="yes">Ligusticum chuanxiong</italic> Hort (chuanxiong), a traditional Chinese medicinal herb [<xref rid="cns70367-bib-0007" ref-type="bibr">7</xref>]. LSZ phosphate is a commercial product for cerebral ischemia [<xref rid="cns70367-bib-0008" ref-type="bibr">8</xref>], is reported to protect the vasculature under cerebral ischemia by reducing oxidative stress [<xref rid="cns70367-bib-0009" ref-type="bibr">9</xref>] and the cascade reaction of apoptosis [<xref rid="cns70367-bib-0010" ref-type="bibr">10</xref>], promoting endothelial cell survival, and maintaining the BBB stability [<xref rid="cns70367-bib-0011" ref-type="bibr">11</xref>]. Increased expression of TJs with LSZ treatment serves as a vital indicator of improved BBB integrity against ischemia injury [<xref rid="cns70367-bib-0012" ref-type="bibr">12</xref>]. However, how LSZ protects the BBB and its underlying mechanism about TJs remains elusive.</p><p>MicroRNAs (miRNAs) are short noncoding RNAs (20&#x02013;22&#x02009;nt) that have pivotal functions in the posttranscriptional regulation of different cellular processes [<xref rid="cns70367-bib-0013" ref-type="bibr">13</xref>, <xref rid="cns70367-bib-0014" ref-type="bibr">14</xref>, <xref rid="cns70367-bib-0015" ref-type="bibr">15</xref>, <xref rid="cns70367-bib-0016" ref-type="bibr">16</xref>, <xref rid="cns70367-bib-0017" ref-type="bibr">17</xref>]. The atypical manifestation of miRNAs has garnered heightened interest due to their substantial impacts on the occurrence and control of diverse diseases [<xref rid="cns70367-bib-0018" ref-type="bibr">18</xref>, <xref rid="cns70367-bib-0019" ref-type="bibr">19</xref>]. Through the regulation of miRNA, LSZ alleviates cell damage and neural apoptosis in injured spinal cords caused by lipopolysaccharide or hypoxia [<xref rid="cns70367-bib-0020" ref-type="bibr">20</xref>, <xref rid="cns70367-bib-0021" ref-type="bibr">21</xref>]. Therefore, we speculated that miRNAs may participate in TJs' responses to LSZ treatment. This study aims to investigate the protective effects of LSZ on the BBB as well as related mechanisms through the regulation of miRNA on occludin.</p></sec><sec sec-type="methods" id="cns70367-sec-0006"><label>2</label><title>Methods</title><sec id="cns70367-sec-0007"><label>2.1</label><title>Cell Culture and Treatments</title><p>Derived from the mouse brain microvascular endothelial cells (BMECs), the BMEC line (b. End3 cells, ATCC, Molsheim Cedex, France) was cultured in Dulbecco's modified Eagle's medium (DMEM; HyClone, Logan, UT, USA) supplemented with 10% fetal bovine serum (Gibco; Australia), and 1% 100&#x02009;IU/mL penicillin/streptomycin (HyClone) at a temperature of 37&#x000b0;C and 5% CO<sub>2</sub> [<xref rid="cns70367-bib-0003" ref-type="bibr">3</xref>]. Cells were passed by using 0.25% EDTA&#x02013;trypsin (HyClone), and the growth medium was changed every 3&#x02009;days once the cells reached confluence.</p><p>B. End3 cells underwent oxygen&#x02013;glucose deprivation (OGD) injury according to the previously mentioned method [<xref rid="cns70367-bib-0005" ref-type="bibr">5</xref>, <xref rid="cns70367-bib-0022" ref-type="bibr">22</xref>]. In order to cause hypoxia, the glucose&#x02010;free DMEM was used to replace the culture medium, and then the cells were perfused with a mixture of 5% CO<sub>2</sub> and 95% N<sub>2</sub> gas at a temperature of 37&#x000b0;C for a duration of 3&#x02009;h. To imitate reperfusion injury, cells were then cultured in normal DMEM for 24&#x02009;h. LSZ was dissolved in PBS and administered to b. End3 cells at concentrations of 0.01, 0.1, 1, 10, 100, or 1000&#x02009;&#x003bc;M. The optimal concentration of LSZ was determined through enzyme&#x02010;linked immunosorbent assays (ELISA) and used in the subsequent experiments. Cells were exposed to drugs throughout the entire period of OGD and reperfusion. After reperfusion, cells were harvested for following assays.</p></sec><sec id="cns70367-sec-0008"><label>2.2</label><title>ELISA</title><p>ELISA kits for occludin were purchased from J&#x00026;L Biological (JL20408; Shanghai, China). Following different treatments, cells were lysed by sonication in RIPA lysis buffer. The manufacturer's instructions were followed to utilize these specific ELISA kits, and a microplate spectrophotometer (Biotek, USA) was employed to measure the absorption at 450&#x02009;nm for each well.</p></sec><sec id="cns70367-sec-0009"><label>2.3</label><title>Animal Experimental Protocol</title><p>The subjects used in the experiments were adult male C57BL/6J mice (aged 6&#x02013;8&#x02009;weeks) obtained from the Experimental Animal Center of Ningxia Medical University General Hospital. Mice were ensconced in a colony room and given unlimited access to food and water. The room was kept at a constant temperature, humidity setting, and light&#x02013;dark schedule (24&#x000b0;C&#x02009;&#x000b1;&#x02009;2&#x000b0;C, 50%&#x02013;60%, 12&#x02009;h light and 12&#x02009;h dark). Mice were acclimatized to laboratory conditions for at least 7&#x02009;days prior to the procedure. All experimental procedures were approved by Ningxia Medical University General Hospital's Animal Ethics Committee (KYLL&#x02010;2024&#x02010;0275). Mice were used in a very limited number, and their suffering was minimized to the greatest extent possible. Mice were administered LSZ (5&#x02009;mg/mL, 25&#x02009;mg/kg, i.p., once daily for 9 consecutive days). The sham treatment involved the use of an equal amount of saline. LSZ was purchased from Yuanye Bio&#x02010;Technology (Shanghai, China) at a purity of 98%.</p></sec><sec id="cns70367-sec-0010"><label>2.4</label><title>Middle Cerebral Artery Occlusion (<styled-content style="fixed-case" toggle="no">MCAO</styled-content>)</title><p>On eighth day, mice underwent MCAO according to the previously mentioned method [<xref rid="cns70367-bib-0023" ref-type="bibr">23</xref>]. Mice were given a combination of nitrous oxide, oxygen, and isoflurane (69%, 30%, and 1%) by inhaling through a mask connected to a rodent anesthesia machine (Matrx, MIDMARK, USA). After exposure of the right carotid bifurcation, a silicone&#x02010;coated filament (size: 8&#x02013;0) was gently advanced (9.0&#x02013;10.0&#x02009;mm) through the common carotid artery to occlude the middle cerebral artery. Cerebral blood flow was reinstated by removing the nylon suture following a temporary blockage lasting 1&#x02009;h. In the sham group, the common carotid arteries were surgically exposed without undergoing MCAO. The surgical procedure was conducted while maintaining the temperature of 37&#x000b0;C&#x02009;&#x000b1;&#x02009;0.5&#x000b0;C.</p></sec><sec id="cns70367-sec-0011"><label>2.5</label><title>Neurobehavioral Evaluation and Infarct Volume Assessment</title><p>Neurobehavioral evaluation was carried out 24&#x02009;h after reperfusion to assess neurological deficits according to Zea&#x02010;Longa's methodology [<xref rid="cns70367-bib-0024" ref-type="bibr">24</xref>]. To assess infarct volume, inhaled anesthesia by virtue of gaseous isoflurane was then used to anesthetize the mice, followed by decapitation by guillotine. The brains were promptly extracted and chilled in ice&#x02010;cold saline for a duration of 10&#x02009;min. The coronal sections were sliced (2&#x02009;mm) and soaked in 2% 2,3,5&#x02010;triphenyltetrazolium chloride (TTC) for 30&#x02009;min under 37&#x000b0;C. After that, they were fixed in a 10% buffered formalin solution for a duration of 24&#x02009;h. Images of brain slices were taken by a digital camera (Kodak DC240, Eastman Kodak Co., Rochester, NY, USA) connected to the computer. To quantify infarcts (areas without staining) in each slice, the measurement was performed using image analysis software (Adobe Photoshop 7.0 CS for Windows). Hence, the volume of infarct was calculated by multiplying the unstained areas of each slice by the slice thickness (2&#x02009;mm) and summing up the volumes of all 5 slices.</p></sec><sec id="cns70367-sec-0012"><label>2.6</label><title>Purification of Hippocampal <styled-content style="fixed-case" toggle="no">RNA</styled-content>
</title><p>Isoflurane&#x02010;anesthetized mice were decapitated. For further analysis, their hippocampi were promptly separated on ice&#x02010;cold glass slides, then transferred into frozen vials with RNA stabilization reagent (QIAGEN, Germany) at 4&#x000b0;C, and finally preserved at &#x02212;80&#x000b0;C according to the previously mentioned method. Using liquid nitrogen, pulverize approximately 60&#x02009;mg of hippocampus into a fine powder and then transfer the powdered samples into a 2&#x02009;mL tube that already contains 1.5&#x02009;mL of Trizol reagent (Life Technologies, Carlsbad, CA, USA). The mixture underwent centrifugation at 12,000&#x02009;<italic toggle="yes">g</italic> for 5&#x02009;min at 4&#x000b0;C. The supernatant was transferred to a new 2&#x02009;mL tube and then 0.3&#x02009;mL of Chloroform/isoamyl alcohol (24:1) was added for every 1.5&#x02009;mL of Trizol reagent. Following the centrifugation of the mixture at 12,000&#x02009;<italic toggle="yes">g</italic> for 10&#x02009;min at 4&#x000b0;C, an equivalent volume of isopropyl alcohol supernatant was added to a new 1.5&#x02009;mL tube containing the aqueous phase. The mixture underwent centrifugation at 12,000&#x02009;<italic toggle="yes">g</italic> for 20&#x02009;min at 4&#x000b0;C, following which the supernatant was discarded. After being washed with 1&#x02009;mL of 75% ethanol, the RNA pellet in the biosafety cabinet was dried by using air. Subsequently, a solution of DEPC&#x02010;treated water (25&#x02013;100&#x02009;&#x003bc;L) was added to dissolve it. The quality of the RNA was assessed through a Nano Drop and Agilent 2100 bioanalyzer (Thermo Fisher Scientific, MA, USA).</p><p>Concentrations of total RNA, RNA integrity numbers (RINs) as well as ratios of 28S ribosomal RNAs to 18S ribosomal RNAs were measured. In addition, the options of the amount of total RNA (&#x0003e;&#x02009;10&#x02009;&#x003bc;g), concentrations (&#x0003e;&#x02009;200&#x02009;ng/&#x003bc;L), RINs (&#x0003e;&#x02009;8), and 28SRNA/18SRNA ratios (&#x0003e;&#x02009;1.0) were used to construct transcriptome and small RNA libraries.</p></sec><sec id="cns70367-sec-0013"><label>2.7</label><title>
<styled-content style="fixed-case" toggle="no">miRNA</styled-content> Library Construction and Sequencing</title><p>For each sample, 1&#x02009;&#x003bc;g RNA was purified through electrophoretic separation on a 15% denaturing urea&#x02010;polyacrylamide gel electrophoresis (PAGE) gel. The 18&#x02013;30&#x02009;nt bands in the marker lane (14&#x02013;30 ssRNA Ladder Marker, TAKARA) were targeted, and small RNAs were connected to adenylated 3&#x02032; adapters that were paired with distinct barcodes, and annealed to unique barcodes, and subsequently joined to 5&#x02032; adapters. After ligating with the adapter, the small RNAs were transcribed into cDNA by using SuperScript II Reverse Transcriptase (Invitrogen, USA). Multiple rounds of PCR amplification were performed through PCR Primer Cocktail and PCR Mix to enrich cDNA fragments (110&#x02013;130&#x02009;bp). Finally, the cDNA fragments were purified using the QIAquick Gel Extraction Kit (QIAGEN, Valencia, CA). Check the distribution of the fragment sizes through the Agilent 2100 bioanalyzer and conduct RT&#x02010;PCR (TaqMan Probe) to qualify and quantify the library, respectively. Sequencing of the ultimate ligation PCR products was performed through the BGISEQ&#x02010;500 platform (BGI&#x02010;Shenzhen, China). In concise, each hippocampus sample was used to construct poly&#x02010;A selected and barcoded RNA&#x02010;Seq libraries by the TruSeq RNA sample prep kit (Illumina, San Diego, CA, USA). Double&#x02010;stranded cDNA was ligated to adapters containing 7 nucleotide indices and purified between enzymatic reactions. For the option of the appropriate size of the library through AMPure XP beads (Beckman Coulter Genomics, Danvers, MA, USA), RNA fragments (17&#x02013;27&#x02009;nt) were isolated by denaturing PAGE (15%) for enriching miRNAs. A small RNA Sample Prep kit (Illumina) was used to construct deep&#x02010;sequencing libraries. Following the ligation of adaptors as the 3&#x02032; and 5&#x02032; ends, the miRNAs were purified and subjected to reverse transcription and low&#x02010;cycle PCR amplification. PCR products were purified by PAGE (8%), followed by sequencing on the Genome Analyzer II (Illumina). DNA High Sensitivity Assay on the LabChip GX (Perkin Elmer, Waltham, MA, USA) was used to quantify libraries. After quantification, the libraries were prepared for sequencing on a 100&#x02010;base paired&#x02010;end Illumina HiSeq 2500 run (Illumina). Functional annotation, clustering, and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed on the identified genes using the database for annotation, visualization, and integrated discovery (<ext-link xlink:href="https://david.ncifcrf.gov/" ext-link-type="uri">https://david.ncifcrf.gov/</ext-link>).</p></sec><sec id="cns70367-sec-0014"><label>2.8</label><title>Western Blot (<styled-content style="fixed-case" toggle="no">WB</styled-content>)</title><p>WB was performed according to the previously mentioned method [<xref rid="cns70367-bib-0025" ref-type="bibr">25</xref>]. Protein quantification was performed by electrotransferring equal amounts of hippocampal proteins (50&#x02009;&#x003bc;g) onto PDVF membranes (Invitrogen). The membranes were then probed with antibodies for polyclonal rabbit antimouse occludin (1:1000; 27260&#x02010;1&#x02010;AP; Proteintech), polyclonal rabbit anti&#x02010;mouse ZO&#x02010;1 (1:1000; 21773&#x02010;1&#x02010;AP; Proteintech), polyclonal rabbit anti&#x02010;mouse caveolin&#x02010;1 (1:1000; ab2910; Abcam), polyclonal rabbit anti&#x02010;mouse caveolin&#x02010;2 (1:1000; AF5409; Affinity), polyclonal rabbit anti&#x02010;mouse caveolin&#x02010;3 (1:1000; ab2912; Abcam), and anti&#x02010;&#x003b2;&#x02010;actin (1:10000; A2228; Sigma&#x02010;Aldrich) served as the loading control. The bands on membranes were made visible by using an ECL system (Absin Bioscience Inc., Shanghai, China) after incubation with horseradish peroxidase&#x02010;conjugated secondary antibodies (anti&#x02010;rabbit/anti&#x02010;mouse IgG for the primary antibodies). Band density was then measured through a Tanon 5200 imager (Tanon, Shanghai, China), and band intensity was measured through comparison to the loading control (&#x003b2;&#x02010;actin).</p></sec><sec id="cns70367-sec-0015"><label>2.9</label><title>Quantitative Real&#x02010;Time <styled-content style="fixed-case" toggle="no">PCR</styled-content> (<styled-content style="fixed-case" toggle="no">qRT</styled-content>&#x02010;<styled-content style="fixed-case" toggle="no">PCR</styled-content>)</title><p>Samples of total RNA from the hippocampi were isolated by miRNAExtractor RNA Isolation Kit (B518811; Sangon, China). For the synthesis of cDNA from the miRNA, the miRNA First&#x02010;Strand cDNA Synthesis Kit (Agilent) was utilized. In order to analyze RNA, SYBR Green (Life Technologies) was employed along with the utilization of the forward primers (Table&#x000a0;<xref rid="cns70367-tbl-0001" ref-type="table">1</xref>).</p><table-wrap position="float" id="cns70367-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Primers sequences in qRT&#x02010;PCR.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><tbody valign="top"><tr><td align="left" colspan="2" valign="top" rowspan="1">Primers for reverse transcription of stem&#x02010;loop sequences</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">miR&#x02010;200c&#x02010;3p</td><td align="center" valign="top" rowspan="1" colspan="1">5&#x02032;&#x02010;CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTCCATCA&#x02010;3&#x02032;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">miR&#x02010;183&#x02010;5p</td><td align="center" valign="top" rowspan="1" colspan="1">5&#x02032;&#x02010;CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGAGTGAATT&#x02010;3&#x02032;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">miR&#x02010;532&#x02010;5p</td><td align="center" valign="top" rowspan="1" colspan="1">5&#x02032;&#x02010;CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGACGGTCCT&#x02010;3&#x02032;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">miR&#x02010;297c&#x02010;5p</td><td align="center" valign="top" rowspan="1" colspan="1">5&#x02032;&#x02010;CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGACATGTAC&#x02010;3&#x02032;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">miR&#x02010;744&#x02010;5p</td><td align="center" valign="top" rowspan="1" colspan="1">5&#x02032;&#x02010;CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTGCTGTTA&#x02010;3&#x02032;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">miR&#x02010;339&#x02010;5p</td><td align="center" valign="top" rowspan="1" colspan="1">5&#x02032;&#x02010;CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGCGTGAGCT&#x02010;3&#x02032;</td></tr><tr><td align="left" colspan="2" valign="top" rowspan="1">Primes for quantitative real&#x02010;time PCR</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">miR&#x02010;200c&#x02010;3p</td><td align="center" valign="top" rowspan="1" colspan="1">5&#x02032;&#x02010;ACACTCCAGCTGGGTAATACTGCCGGGTAA&#x02010;3&#x02032;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">miR&#x02010;183&#x02010;5p</td><td align="center" valign="top" rowspan="1" colspan="1">5&#x02032;&#x02010;ACACTCCAGCTGGGTATGGCACTGGTAG&#x02010;3&#x02032;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">miR&#x02010;532&#x02010;5p</td><td align="center" valign="top" rowspan="1" colspan="1">5&#x02032;&#x02010;ACACTCCAGCTGGGCATGCCTTGAGTGT&#x02010;3&#x02032;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">miR&#x02010;297c&#x02010;5p</td><td align="center" valign="top" rowspan="1" colspan="1">5&#x02032;&#x02010;ACACTCCAGCTGGGATGTATGTGTGCAT&#x02010;3&#x02032;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">miR&#x02010;744&#x02010;5p</td><td align="center" valign="top" rowspan="1" colspan="1">5&#x02032;&#x02010;ACACTCCAGCTGGGTGCGGGGCTAGGGC&#x02010;3&#x02032;</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">miR&#x02010;339&#x02010;5p</td><td align="center" valign="top" rowspan="1" colspan="1">5&#x02032;&#x02010;ACACTCCAGCTGGGTCCCTGTCCTCCAGG&#x02010;3&#x02032;</td></tr><tr><td align="left" colspan="2" valign="top" rowspan="1">Unified reverse primer</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" valign="top" rowspan="1">5&#x02032;&#x02010;TGGTGTCGTGGAGTCG&#x02010;3&#x02032;</td></tr><tr><td align="left" colspan="2" valign="top" rowspan="1">Forward U6</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" valign="top" rowspan="1">5&#x02032;&#x02010;CTCGCTTCGGCAGCACA&#x02010;3&#x02032;</td></tr><tr><td align="left" colspan="2" valign="top" rowspan="1">Reverse U6</td></tr><tr><td align="left" style="padding-left:10%" colspan="2" valign="top" rowspan="1">5&#x02032;&#x02010;AACGCTTCACGAATTTGCGT&#x02010;3&#x02032;</td></tr></tbody></table></table-wrap><p>The relative ratio of miRNAs in each sample was determined through threshold cycles and appropriate software (StepOne, ABI, USA) according to the instructions provided. For the standardization of miRNA expression, U6 was employed as a housekeeping gene for internal control.</p></sec><sec id="cns70367-sec-0016"><label>2.10</label><title>Target Prediction</title><p>For the prediction of the binding to the 3&#x02032;UTR of <italic toggle="yes">Ocln</italic>, MiRanda v3.3a (<ext-link xlink:href="http://www.targetscan.org/" ext-link-type="uri">http://www.miranda.org/</ext-link>), MiRDB v6.0 (<ext-link xlink:href="http://www.targetscan.org/" ext-link-type="uri">http://www.mirdb.org/</ext-link>) as well as TargetScan v7.2 (<ext-link xlink:href="http://www.targetscan.org/" ext-link-type="uri">http://www.targetscan.org/</ext-link>) were utilized. Potential target intersections were demonstrated through a Venn diagram.</p></sec><sec id="cns70367-sec-0017"><label>2.11</label><title>Transfection With <styled-content style="fixed-case" toggle="no">miRNA</styled-content> Agomirs and Antagomirs</title><p>RNA oligoribonucleotides in Table&#x000a0;<xref rid="cns70367-tbl-0002" ref-type="table">2</xref> were acquired from Sangon Biotech (Shanghai, China) and employed for transfection in six&#x02010;well plates by Lipofectamine 3000 Transfection Reagent (Invitrogen, Carlsbad, CA, USA) following the instructions provided by the manufacturers. For the assessment of the impact of miR&#x02010;297c&#x02010;5p on occludin and caveolins, b. End3 cells were subjected to transfection with a combination of 20&#x02009;&#x003bc;M miR&#x02010;297c&#x02010;5p Agomir or Antagomir (RiboBio, China) and Lipofectamine 3000 Reagent in Opti&#x02010;MEM (HyClone, Logan, UT, USA) according to the instructions provided. Different scrambled sequences were used as a negative control (NC) or inhibitor NC. The cells were incubated with DMEM 7&#x02009;h after transfection and then harvested for further analysis after 24&#x02009;h. Confirmation of transfection efficiency was achieved by transfecting the FAM&#x02010;labeled agomir and subsequently observing it under a confocal laser microscope (FV1000, Olympus, Japan). The microscope captured images by using standard laser lines and filters.</p><table-wrap position="float" id="cns70367-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Sequences for agomirs and antagomirs of scramble and miR&#x02010;297c&#x02010;5p.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><tbody valign="top"><tr><td align="left" rowspan="2" valign="top" colspan="1">Scramble agomir</td><td align="center" valign="top" rowspan="1" colspan="1">2&#x02032;&#x02010;O&#x02010;methylated&#x02010;sulfo&#x02010;5&#x02032;&#x02010;FAM&#x02010;UUCUCCGAACGUGUCACGUTT&#x02010;cholesterol&#x02010;3&#x02032; (sense)</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">2&#x02032;&#x02010;O&#x02010;methylated&#x02010;sulfo&#x02010;5&#x02032;&#x02010;ACGUGACACGUUCGGAGAATT&#x02010;cholesterol&#x02010;3&#x02032; (antisense)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Scramble antagomir</td><td align="center" valign="top" rowspan="1" colspan="1">2&#x02032;&#x02010;O&#x02010;methylated&#x02010;sulfo&#x02010;5&#x02032;&#x02010;CAGUAGUUUUGUGUAGUACAA&#x02010;cholesterol&#x02010;3&#x02032;</td></tr><tr><td align="left" rowspan="2" valign="top" colspan="1">miR&#x02010;297c&#x02010;5p agomir</td><td align="center" valign="top" rowspan="1" colspan="1">2&#x02032;&#x02010;O&#x02010;methylated&#x02010;sulfo&#x02010;5&#x02032;&#x02010;AUGUAUGUGUGCAUGUACAUGU&#x02010;cholesterol&#x02010;3&#x02032; (sense)</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">2&#x02032;&#x02010;Omethylated&#x02010;sulfo&#x02010;5&#x02032;&#x02010;ACAUGUACAUGCACACAUACAU&#x02010;cholesterol&#x02010;3&#x02032; (antisense)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">miR&#x02010;297c&#x02010;5p antagomir</td><td align="center" valign="top" rowspan="1" colspan="1">2&#x02032;&#x02010;O&#x02010;methylated&#x02010;sulfo&#x02010;5&#x02032;&#x02010;ACAUGUACAUGCACACAUACAU&#x02010;cholesterol&#x02010;3&#x02032;</td></tr></tbody></table></table-wrap></sec><sec id="cns70367-sec-0018"><label>2.12</label><title>Stereotaxic Injection of Adeno&#x02010;Associated Virus (<styled-content style="fixed-case" toggle="no">AAV</styled-content>) Vectors</title><p>For miR&#x02010;297c&#x02010;5p overexpression, AAV vectors were designed and produced in conjunction with the expression of green fluorescent protein (GFP) under the CAG promoter (Sangon, China) in AAV&#x02010;293 cells. The procedure for stereotaxic injection of AAV vector was performed according to the previously mentioned method [<xref rid="cns70367-bib-0026" ref-type="bibr">26</xref>]. In brief, mice received inhaled anesthesia through gaseous isoflurane and were placed on a stereotaxic apparatus (Reward, Shenzhen, China). AAVs (&#x0003e;&#x02009;10<sup>12</sup> v.g./mL) were then stereotaxically microinjected into the unilateral CA1 area of the hippocampus (mediolateral, &#x000b1;1.70&#x02009;mm; anteroposterior, +2.30&#x02009;mm; dorsoventral, &#x02212;1.70&#x02009;mm) according to the following coordinates from the mouse brain atlas [<xref rid="cns70367-bib-0027" ref-type="bibr">27</xref>] by a microinjection pump (ALC&#x02010;IP600L, Beijing, China) at a rate of 20&#x02009;nL/min for a duration of 25&#x02009;min/side. Scrambled AAV vectors encoding GFP were injected into symmetrical areas in the brains of the former mice. At the end, holes were sealed with bone wax, and there were 4&#x02009;weeks after stereotaxic injections and before further experiments.</p></sec><sec id="cns70367-sec-0019"><label>2.13</label><title>Guide Cannula Implantation and Microinjection</title><p>After 7&#x02010;day acclimation, mice got inhaled anesthesia and were placed on a stereotaxic apparatus. A stainless&#x02010;steel guide cannula (7.0&#x02009;mm, 27 gauge; Reward, Shenzhen, China) was inserted into the right hemisphere of mice above the hippocampus. The tip of the cannula ended 1.0&#x02013;1.5&#x02009;mm above the hippocampus, positioned at mediolateral coordinates of &#x000b1;1.70&#x02009;mm, anteroposterior coordinates of +2.30&#x02009;mm, and dorsoventral coordinates of&#x02014;1.70&#x02009;mm. Three stainless steel screws and dental cements were utilized to secure guide cannulas to the skull. For avoidance of occlusive occurrence, guide cannulas were equipped with detachable cannulas (34 gauge; Reward, Shenzhen, China) that were inserted along the entire length. The surgical procedure was conducted while maintaining the temperature of 37&#x000b0;C&#x02009;&#x000b1;&#x02009;0.5&#x000b0;C.</p><p>Intrabrain microinjection was started on seventh day after surgery. A microinjection pump was used to administer RNA oligos (20&#x02009;&#x003bc;M miR&#x02010;297c&#x02010;5p agomir, antagomir, and scramble) at a rate of 0.1&#x02009;&#x003bc;L/min for a duration of 10&#x02009;min. RNA oligo was injected three times within 7&#x02009;days. An equal volume of saline was injected in the sham group. After the MCAO procedure, mice were administered LSZ (5&#x02009;mg/mL, 25&#x02009;mg/kg, i.p., once daily for 9 consecutive days). The sham treatment involved the utilization of an equivalent amount of saline.</p></sec><sec id="cns70367-sec-0020"><label>2.14</label><title>Dual&#x02010;Luciferase Activity Assay</title><p>For confirmation whether occludin is a direct target of miR&#x02010;297c&#x02010;5p, a luciferase reporter assay was performed. PmiRGLO dual luciferase vectors carrying the WT and mutated 3&#x02032;UTR of <italic toggle="yes">Ocln</italic> were, respectively, designated as wild&#x02010;type and mutant&#x02010;type <italic toggle="yes">Ocln</italic>. The design of the mutated 3&#x02019; UTR of <italic toggle="yes">Ocln</italic> is complementary to the base sequence of the WT. MiR&#x02010;297c&#x02010;5p mimics or mimics&#x02010;NC (Sangon Co. Ltd., Shanghai, China) were transiently cotransfected with the luciferase reporter plasmid in HEK&#x02010;293&#x02009;T cells. After incubating at 37&#x000b0;C for 48&#x02009;h, the cells that underwent transfection were gathered to measure luciferase activity through the Dual&#x02010;Luciferase Reporter Assay System (Promega, Fitchburg, WI, USA) according to the instructions provided.</p></sec><sec id="cns70367-sec-0021"><label>2.15</label><title>Statistics</title><p>Data were denoted as mean&#x02009;&#x000b1;&#x02009;SEM. Normal/Gaussian distribution was confirmed by the Brown&#x02010;Forsythe test. Statistical comparisons were performed by using either the unpaired Student's <italic toggle="yes">t</italic>&#x02010;test or one&#x02010;/two&#x02010;way ANOVA. If the result of ANOVA yielded a significant result, subsequent tests such as the least significant difference (LSD) test or Dunnett's test (GraphPad Prism 8.3.0) were conducted. Following the adjustment for lower&#x02010;bound impacts, the repeated measurement data underwent analysis through univariate ANOVA with statistical significance indicated by a <italic toggle="yes">p</italic>&#x02010;value of less than 0.05.</p></sec></sec><sec sec-type="results" id="cns70367-sec-0022"><label>3</label><title>Results</title><sec id="cns70367-sec-0023"><label>3.1</label><title>
<styled-content style="fixed-case" toggle="no">LSZ</styled-content> Reversed <styled-content style="fixed-case" toggle="no">OGD</styled-content>&#x02010;Induced Downregulation of Occludin and <styled-content style="fixed-case" toggle="no">ZO</styled-content>&#x02010;1</title><p>OGD serves as a classical in&#x000a0;vitro model of the BBB damage [<xref rid="cns70367-bib-0028" ref-type="bibr">28</xref>]. An important indicator of the BBB disruption is a marked reduction of TJs in BMECs [<xref rid="cns70367-bib-0029" ref-type="bibr">29</xref>]. As expected, occludin and ZO&#x02010;1 levels decreased in b. End3 cells subjected to OGD for 3&#x02009;h (Figure&#x000a0;<xref rid="cns70367-fig-0001" ref-type="fig">1A,B</xref>). ELISA revealed that the decrease in occludin observed after 3&#x02010;h OGD treatment could be significantly reversed by 0.1 and 1&#x02009;&#x003bc;M LSZ but not by the administration of higher concentrations of LSZ (10, 100 and 1000&#x02009;&#x003bc;M, Figure&#x000a0;<xref rid="cns70367-fig-0001" ref-type="fig">1C</xref>). WB further indicated that 0.1&#x02009;&#x003bc;M LSZ could increase occludin and ZO&#x02010;1 levels in the saline and OGD&#x02010;treated cells (Figure&#x000a0;<xref rid="cns70367-fig-0001" ref-type="fig">1D,E</xref>). These results demonstrate that LSZ may protect the BBB by increasing expressions of TJs.</p><fig position="float" fig-type="FIGURE" id="cns70367-fig-0001"><label>FIGURE 1</label><caption><p>LSZ increased levels of TJs in b. End3cells treated with OGD. (A) Representative WB analysis of occludin and ZO&#x02010;1. (B) Levels of occludin and ZO&#x02010;1 in b. End3 cells treated with OGD for 3&#x02009;h. (C) Levels of occludin in b. End3 cells treated with OGD for 3&#x02009;h and the effects of LSZ in ELISA. (D) Representative WB analysis of occludin and ZO&#x02010;1. (E) Levels of occludin and ZO&#x02010;1 in cells with 3&#x02010;h OGD and LSZ treatment. Data are presented as means &#x000b1; SEM, <italic toggle="yes">n</italic>&#x02009;=&#x02009;6 in each group. **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001 versus sham group; #<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, ##<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 versus OGD group.</p></caption><graphic xlink:href="CNS-31-e70367-g003" position="anchor" id="jats-graphic-3"/></fig></sec><sec id="cns70367-sec-0024"><label>3.2</label><title>
<styled-content style="fixed-case" toggle="no">MiRNA</styled-content> Sequencing Revealed Alterations in <styled-content style="fixed-case" toggle="no">miRNAs</styled-content> and Potential Targets</title><p>For elucidation of the mechanism underlying the regulation of LSZ on TJs, miRNA sequencing was performed in hippocampal samples. Different color blocks in the heat map generated indicated differentially expressed gene levels in samples (Figure&#x000a0;<xref rid="cns70367-fig-0002" ref-type="fig">2A</xref>). Figure&#x000a0;<xref rid="cns70367-fig-0002" ref-type="fig">2B</xref> lists the top 10 genes showing decreased and increased expression (|log<sub>2</sub>FC|&#x02009;&#x02265;&#x02009;1.0; <italic toggle="yes">Q</italic> value &#x02264;&#x02009;0.05).</p><fig position="float" fig-type="FIGURE" id="cns70367-fig-0002"><label>FIGURE 2</label><caption><p>Bioinformatics analysis and qRT&#x02010;PCR verification for miRNAs. (A) Heat map of miRNAs in mice with and without LSZ treatment. Different color blocks stand for differtent expression levels in each sample. Study significance was defined as a difference of 2.0 folds (|log<sub>2</sub>FC|&#x02009;&#x02265;&#x02009;1.0; <italic toggle="yes">Q</italic> value &#x02264;&#x02009;0.05, <italic toggle="yes">n</italic>&#x02009;=&#x02009;4 in each group). (B) KEGG pathway analyses of top 10 downregulated and 10 upregulated miRNAs. (C) Top 23 enriched pathways in an ascending order. The vertical axis denotes the pathway category, the horizontal axis above (orange line) denotes the degree of enrichemnt of the pathway, and the horizontal axis below (blue bars) denotes the enrichment significance. (D) QRT&#x02010;PCR verification of predict miRNAs including miR&#x02010;200c&#x02010;3p, miR&#x02010;183&#x02010;5p, miR&#x02010;532&#x02010;5p, miR&#x02010;297c&#x02010;5p, miR&#x02010;744&#x02010;5p, and miR&#x02010;339&#x02010;5p. Data are presented as means &#x000b1; SEM, <italic toggle="yes">n</italic>&#x02009;=&#x02009;5 in each group. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 versus saline group. (E) Venn diagram showing the target proteins of miR&#x02010;297c&#x02010;5p by MiRanda, MiRDB, and TargetScan. (F) Network diagram showing the potential target genes of miR&#x02010;297c&#x02010;5p and the gene list (G).</p></caption><graphic xlink:href="CNS-31-e70367-g005" position="anchor" id="jats-graphic-5"/></fig><p>KEGG pathway enrichment analysis was performed to screen the target genes of 20 miRNAs. The top 23 enriched KEGG pathway items are listed in Figure&#x000a0;<xref rid="cns70367-fig-0002" ref-type="fig">2C</xref>. The target genes showed a notable enrichment in the functional categories related to hippocampus signaling pathways, such as actin cytoskeleton, endocytosis, adherens junction, gap junction, apoptosis, VEGF signaling, tight junction, protein export, etc. Data analysis further supported the regulation of LSZ exerted on junction&#x02010;related pathways in the BBB. QRT&#x02010;PCR was performed to evaluate miRNAs with high |log<sub>2</sub>FC| and low <italic toggle="yes">Q</italic> value in the saline and LSZ&#x02010;treated groups, which confirmed the differential expression of miRNAs in the hippocampus. In LSZ&#x02010;treated mice, miR&#x02010;200c&#x02010;3p and miR&#x02010;183&#x02010;5p showed significant increases, whereas miR&#x02010;297c&#x02010;5p and miR&#x02010;744&#x02010;5p exhibited decreases compared to the mice treated with saline (Figure&#x000a0;<xref rid="cns70367-fig-0002" ref-type="fig">2D</xref>). MiR&#x02010;297c&#x02010;5p received attention as a target in subsequent experiments because of significant changes with the lowest <italic toggle="yes">Q</italic> value after LSZ administration. For the prediction of the target genes of miR&#x02010;297c&#x02010;5p, various algorithms such as MiRanda, MiRDB, and TargetScan [<xref rid="cns70367-bib-0030" ref-type="bibr">30</xref>] were utilized. The predicted target gene numbers and names are presented in Figure&#x000a0;<xref rid="cns70367-fig-0002" ref-type="fig">2E&#x02013;G</xref>.</p></sec><sec id="cns70367-sec-0025"><label>3.3</label><title>Effects of <styled-content style="fixed-case" toggle="no">LSZ</styled-content> on Brain Injury and Levels of <styled-content style="fixed-case" toggle="no">miR</styled-content>&#x02010;297c&#x02010;5p in Mice With <styled-content style="fixed-case" toggle="no">MCAO</styled-content>
</title><p>The neurological function of LSZ was evaluated in the MCAO mouse model. LSZ treatment (25&#x02009;mg/kg, i.p., once daily for 9 consecutive days; Figure&#x000a0;<xref rid="cns70367-fig-0003" ref-type="fig">3A</xref>) significantly reduced neurological impairments in MCAO mice. TTC staining demonstrated that LSZ significantly decreased the infarction volume (Figure&#x000a0;<xref rid="cns70367-fig-0003" ref-type="fig">3B,C</xref>). QRT&#x02010;PCR showed that LSZ reduced the increases of miR&#x02010;297c&#x02010;5p in MCAO mice (Figure&#x000a0;<xref rid="cns70367-fig-0003" ref-type="fig">3D</xref>).</p><fig position="float" fig-type="FIGURE" id="cns70367-fig-0003"><label>FIGURE 3</label><caption><p>LSZ reversed the levels of miR&#x02010;297c&#x02010;5p in mice with MCAO. (A) LSZ treatment significantly abated neurological deficit induced by MCAO in mice. Data are presented as means &#x000b1; SEM, <italic toggle="yes">n</italic>&#x02009;=&#x02009;6 in each group. (B) Representative photographs after MCAO and treatment; white area representing the infarct region. (C) Percentage of infarct volume after MCAO in TTC. Data are presented as means &#x000b1; SEM, <italic toggle="yes">n</italic>&#x02009;=&#x02009;3 in each group. (D) Levels of miR&#x02010;297c&#x02010;5p in hippocampus of different groups by quantitative PCR. Data are presented as means &#x000b1; SEM, <italic toggle="yes">n</italic>&#x02009;=&#x02009;6 in each group. ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001 versus sham group; #<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, ##<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 versus MCAO group.</p></caption><graphic xlink:href="CNS-31-e70367-g001" position="anchor" id="jats-graphic-7"/></fig></sec><sec id="cns70367-sec-0026"><label>3.4</label><title>Effects of <styled-content style="fixed-case" toggle="no">miR</styled-content>&#x02010;297c&#x02010;5p on Occludin and Caveolins in b. End3 Cells</title><p>For verification whether there was a targeting effect of miR&#x02010;297c&#x02010;5p on occludin and caveolins, miR&#x02010;297c&#x02010;5p agomir and antagomir were transfected into b. End3 cells. A transfection efficiency of up to 74.0%&#x02009;&#x000b1;&#x02009;1.4% was obtained (Figure&#x000a0;<xref rid="cns70367-fig-0004" ref-type="fig">4A</xref>). In b. End3 cells, the occludin level was reduced by transfection with miR&#x02010;297c&#x02010;5p agomir, whereas transfection with miR&#x02010;297c&#x02010;5p antagomir increased occludin compared to the scramble (Figure&#x000a0;<xref rid="cns70367-fig-0004" ref-type="fig">4B,C</xref>). The impact of miR&#x02010;297c&#x02010;5p on caveolins was analyzed, revealing a significant rise in caveolin&#x02010;1, caveolin&#x02010;2, and caveolin&#x02010;3 levels with the administration of miR&#x02010;297c&#x02010;5p agomir. Conversely, the use of miR&#x02010;297c&#x02010;5p antagomir led to a noticeable reduction in these levels compared to the scramble (Figure&#x000a0;<xref rid="cns70367-fig-0004" ref-type="fig">4D,F</xref>). The data indicate that miR&#x02010;297c&#x02010;5p may directly target the gene of occludin.</p><fig position="float" fig-type="FIGURE" id="cns70367-fig-0004"><label>FIGURE 4</label><caption><p>MiR&#x02010;297c&#x02010;5p transfection regulated the levels of occludin in b. End3 cells. (A) Transfection efficiency was detected under confocal microscope. The pseudo red color was postprocessing of FAM color. (B) Representative of WB analysis of occludin, caveolin&#x02010;1, caveolin&#x02010;2, and caveolin&#x02010;3 in different treatments. (C) MiR&#x02010;297c&#x02010;5p agomir decreased levels of occludin, but miR&#x02010;297c&#x02010;5p antagomir increased it. MiR&#x02010;297c&#x02010;5p agomir increased levels of caveolin&#x02010;1 (D), caveolin&#x02010;2 (E), and caveolin&#x02010;3 (F), but miR&#x02010;297c&#x02010;5p antagomir decreased them. Data are presented as means &#x000b1; SEM, <italic toggle="yes">n</italic>&#x02009;=&#x02009;6 experiments in each group. *<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001 versus sham group; #<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, ##<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, ###<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001 versus miR&#x02010;297c&#x02010;5p agomir/antagomir group.</p></caption><graphic xlink:href="CNS-31-e70367-g004" position="anchor" id="jats-graphic-9"/></fig></sec><sec id="cns70367-sec-0027"><label>3.5</label><title>
<styled-content style="fixed-case" toggle="no">MiR</styled-content>&#x02010;297c&#x02010;5p Regulated the Level of Occludin In&#x000a0;Vivo</title><p>Stereotactic injection of AAV&#x02010;miR&#x02010;297c&#x02010;5p into the CA1 area of the hippocampus was performed to overexpress miR&#x02010;297c&#x02010;5p (Figure&#x000a0;<xref rid="cns70367-fig-0005" ref-type="fig">5A</xref>). The level of occludin was detected by WB 4&#x02009;weeks after AAV injection, and it was shown that the injection of AAV&#x02010;miR&#x02010;297c&#x02010;5p decreased the occludin level compared to the scramble (Figure&#x000a0;<xref rid="cns70367-fig-0005" ref-type="fig">5B,C</xref>). This result confirms that miR&#x02010;297c&#x02010;5p may regulate the expression of occludin in&#x000a0;vivo.</p><fig position="float" fig-type="FIGURE" id="cns70367-fig-0005"><label>FIGURE 5</label><caption><p>MiR&#x02010;297c&#x02010;5p involved in regulating occludin in&#x000a0;vivo. (A) The virus expression site in the hippocampus was detected by GFP expression on AAV under a confocal microscope. (B) Representative of WB analysis of occludin. (C) AAV&#x02010;miR&#x02010;297c&#x02010;5p significantly decreased the expression of occludin. Data are presented as means &#x000b1; SEM; <italic toggle="yes">n</italic>&#x02009;=&#x02009;6 in each group. **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 versus Scramble group.</p></caption><graphic xlink:href="CNS-31-e70367-g008" position="anchor" id="jats-graphic-11"/></fig></sec><sec id="cns70367-sec-0028"><label>3.6</label><title>Verification of the Target Gene of <styled-content style="fixed-case" toggle="no">miR</styled-content>&#x02010;297c&#x02010;5p</title><p>For confirmation of targeting impact of miR&#x02010;297c&#x02010;5p on the 3&#x02032;UTR of <italic toggle="yes">Ocln</italic> mRNA, a dual&#x02010;luciferase reporter assay was conducted in HEK293 cells. Bioinformatics analysis revealed that <italic toggle="yes">Ocln</italic> was a supposed target of miR&#x02010;297c&#x02010;5, as shown by the matching sequences in Figure&#x000a0;<xref rid="cns70367-fig-0006" ref-type="fig">6A</xref>. Co&#x02010;transfection of the pGL3&#x02010;<italic toggle="yes">Ocln</italic>&#x02010;3&#x02032;&#x02010;UTR with miR&#x02010;297c&#x02010;5p mimics in HEK293 cells significantly downregulated the relative luciferase activity compared to that of the mimics NC after 48&#x02009;h incubation. Nevertheless, the co&#x02010;transfection of miR&#x02010;297c&#x02010;5p mimics or mimics NC with the pGL3&#x02010;<italic toggle="yes">Ocln</italic>&#x02010;mutated&#x02010;3&#x02032;&#x02010;UTR (containing mutations in the predicted consensus sequences for miR&#x02010;297c&#x02010;5p) did not display any noticeable impact on luciferase activity compared to the co&#x02010;transfection of mimics NC and pGL3&#x02010;<italic toggle="yes">Ocln</italic>&#x02010;3&#x02032;&#x02010;UTR following a 48&#x02010;h incubation period (Figure&#x000a0;<xref rid="cns70367-fig-0006" ref-type="fig">6B</xref>). The data thus indicate that miR&#x02010;297c&#x02010;5p targets the gene <italic toggle="yes">Ocln</italic> (occludin) directly.</p><fig position="float" fig-type="FIGURE" id="cns70367-fig-0006"><label>FIGURE 6</label><caption><p>MiR&#x02010;297c&#x02010;5p directly targeted occludin by dual&#x02010;luciferase activity assay. (A) Alignment of binding sequences for miR&#x02010;297c&#x02010;5p in the 3&#x02032;&#x02010;UTRs of <italic toggle="yes">Ocln</italic> mRNA. (B) The intensity of interaction between miR&#x02010;297c&#x02010;5p and 3&#x02032;&#x02010;UTRs of <italic toggle="yes">Ocln</italic> mRNA was detected by luciferase reporter assay after 48&#x02009;h incubation. Data are presented as means &#x000b1; SEM; <italic toggle="yes">n</italic>&#x02009;=&#x02009;3 in each group. ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001 versus mimics NC group.</p></caption><graphic xlink:href="CNS-31-e70367-g007" position="anchor" id="jats-graphic-13"/></fig></sec><sec id="cns70367-sec-0029"><label>3.7</label><title>Effects of <styled-content style="fixed-case" toggle="no">miR</styled-content>&#x02010;297c&#x02010;5p in Regulation of <styled-content style="fixed-case" toggle="no">LSZ</styled-content> on Occludin in <styled-content style="fixed-case" toggle="no">MCAO</styled-content> Model</title><p>After microinjection of RNA oligos into the CA1 area of the hippocampus combined with LSZ treatment in MCAO mice, neurological function was assessed first. miR&#x02010;297c&#x02010;5p antagomir slightly decreased the scores in MCAO mice compared to that of MCAO injury only (Figure&#x000a0;<xref rid="cns70367-fig-0007" ref-type="fig">7A</xref>). The level of occludin detected by WB showed that MCAO injury obviously downregulated occludin, and scramble microinjection together with LSZ treatment in MCAO mice significantly reversed the downregulation of occludin. Moreover, miR&#x02010;297c&#x02010;5p agomir microinjection in MCAO mice coupled with LSZ decreased occludin compared to the scramble&#x02010;treated group, and miR&#x02010;297c&#x02010;5p antagomir in MCAO mice increased occludin compared to that of MCAO injury only (Figure&#x000a0;<xref rid="cns70367-fig-0007" ref-type="fig">7B,C</xref>).</p><fig position="float" fig-type="FIGURE" id="cns70367-fig-0007"><label>FIGURE 7</label><caption><p>The verification of miR&#x02010;297c&#x02010;5p targeting occludin in MCAO model. (A) Neurological deficit was analyzed in MCAO mice after pretreatment of RNA oligo and LSZ. (B) Representative of WB analysis of occludin. (C) Level of occludin expression was presented as means &#x000b1; SEM, <italic toggle="yes">n</italic>&#x02009;=&#x02009;3 in each group. **<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.001 versus sham group, #<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05, ##<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.01 versus MCAO group, $<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 versus scramble group (Scram: Scramble, Ago:Agomir, Anta:Antagomir).</p></caption><graphic xlink:href="CNS-31-e70367-g006" position="anchor" id="jats-graphic-15"/></fig></sec></sec><sec sec-type="discussion" id="cns70367-sec-0030"><label>4</label><title>Discussion</title><p>Neurological diseases remain the main killer worldwide [<xref rid="cns70367-bib-0017" ref-type="bibr">17</xref>, <xref rid="cns70367-bib-0031" ref-type="bibr">31</xref>, <xref rid="cns70367-bib-0032" ref-type="bibr">32</xref>, <xref rid="cns70367-bib-0033" ref-type="bibr">33</xref>, <xref rid="cns70367-bib-0034" ref-type="bibr">34</xref>]. Among them, the BBB consists of protein transporters and a cellular barrier, which is made up of cells and intercellular connections. The BBB's endothelium, comprising specialized microvascular endothelial cells, has a critical function in safeguarding the CNS against infections and toxins in the everchanging bloodstream environment to maintain brain homeostasis [<xref rid="cns70367-bib-0035" ref-type="bibr">35</xref>]. The preservation and regeneration of BMECs can potentially decrease neuronal harm caused by ischemic attack through the restructuring of injured tissue [<xref rid="cns70367-bib-0036" ref-type="bibr">36</xref>], formation of new blood vessels [<xref rid="cns70367-bib-0003" ref-type="bibr">3</xref>], and stimulation of neurogenesis [<xref rid="cns70367-bib-0037" ref-type="bibr">37</xref>]. Endothelial cells restrict water&#x02010;soluble substances from passing and also control endocytosis and pinocytosis [<xref rid="cns70367-bib-0038" ref-type="bibr">38</xref>]. In the paracellular pathway, substances cross the BBB by virtue of TJs [<xref rid="cns70367-bib-0039" ref-type="bibr">39</xref>]. Predominant TJs include occludin, ZO&#x02010;1, and claudins [<xref rid="cns70367-bib-0040" ref-type="bibr">40</xref>]. When these proteins are pathologically altered, the BBB is broken down and cerebral edema appears [<xref rid="cns70367-bib-0004" ref-type="bibr">4</xref>]. Therefore, drugs protecting BMECs and TJs are suitable for neuronal reparative therapy [<xref rid="cns70367-bib-0041" ref-type="bibr">41</xref>, <xref rid="cns70367-bib-0042" ref-type="bibr">42</xref>].</p><p>LSZ protects the integrity of the BBB during instances of traumatic brain injury [<xref rid="cns70367-bib-0043" ref-type="bibr">43</xref>]. The underlying mechanisms include the anti&#x02010;inflammation pathway through adenosine receptors [<xref rid="cns70367-bib-0044" ref-type="bibr">44</xref>], and JAK/STAT signaling may involve in neuroprotection [<xref rid="cns70367-bib-0012" ref-type="bibr">12</xref>, <xref rid="cns70367-bib-0045" ref-type="bibr">45</xref>]. In the present study, it was found that LSZ protected the BBB by regulating miR&#x02010;297c&#x02010;5p, which targeted <ext-link xlink:href="https://www.sciencedirect.com/topics/neuroscience/occludin" ext-link-type="uri">occludin</ext-link>. The administration of LSZ resulted in elevated levels of occludin and ZO&#x02010;1, which serve to safeguard the integrity of the BBB from harm. Additionally, LSZ has been reported in several studies to exhibit anti&#x02010;inflammatory and antiapoptotic effects, both of which play crucial roles in neuroprotection [<xref rid="cns70367-bib-0046" ref-type="bibr">46</xref>, <xref rid="cns70367-bib-0047" ref-type="bibr">47</xref>]. For instance, LSZ has been shown to attenuate inflammatory responses through the modulation of inflammatory cytokines and NF&#x02010;&#x003ba;B signaling [<xref rid="cns70367-bib-0048" ref-type="bibr">48</xref>, <xref rid="cns70367-bib-0049" ref-type="bibr">49</xref>], and has demonstrated the ability to reduce neuronal apoptosis via the regulation of apoptotic proteins, such as caspases and Bcl&#x02010;2 family members [<xref rid="cns70367-bib-0050" ref-type="bibr">50</xref>, <xref rid="cns70367-bib-0051" ref-type="bibr">51</xref>]. These anti&#x02010;inflammatory and antiapoptotic effects may work synergistically with the BBB protection observed in the current study, offering a multi&#x02010;faceted approach to protecting the brain from ischemic damage.</p><p>MiRNAs play a vital role in the regulation of posttranscriptional gene silencing and are implicated in pathogenic and pathological aspects of ischemic stroke [<xref rid="cns70367-bib-0052" ref-type="bibr">52</xref>, <xref rid="cns70367-bib-0053" ref-type="bibr">53</xref>]. Under both normal and abnormal circumstances, miRNAs in the brain's endothelial cells have significant roles in controlling the functions of the BBB [<xref rid="cns70367-bib-0054" ref-type="bibr">54</xref>, <xref rid="cns70367-bib-0055" ref-type="bibr">55</xref>]. Previous studies have highlighted that miRNAs like miR&#x02010;146a [<xref rid="cns70367-bib-0056" ref-type="bibr">56</xref>], miR&#x02010;155 [<xref rid="cns70367-bib-0057" ref-type="bibr">57</xref>], miR&#x02010;145 [<xref rid="cns70367-bib-0058" ref-type="bibr">58</xref>], and miR&#x02010;21 [<xref rid="cns70367-bib-0021" ref-type="bibr">21</xref>] contribute to BBB integrity through their involvement in inflammation modulation, fibrosis inhibition, and apoptosis reduction. On the one hand, the interactions between miRNA and targeted genes may affect processes including BBB disruption [<xref rid="cns70367-bib-0059" ref-type="bibr">59</xref>], neuronal death [<xref rid="cns70367-bib-0060" ref-type="bibr">, 60</xref>] and tissue infarction [<xref rid="cns70367-bib-0061" ref-type="bibr">61</xref>]. On the other hand, given that miRNAs typically act in networks, their interactions with key signaling pathways need to be explored in greater depth to better understand their collective roles in neuroprotection.</p><p>In the current study, it was shown that LSZ treatment in&#x000a0;vitro significantly increased occludin and ZO&#x02010;1 levels in the OGD group, and in&#x000a0;vivo attenuated the observed increase of miR&#x02010;297c&#x02010;5p, which directly targeted occludin. However, among several candidates of miRNA after miRNA sequencing, only the most differentially expressed RNA was chosen for a series of experiments that followed, and other miRNAs were excluded besides miR&#x02010;297c&#x02010;5p. In the previous studies, it was revealed that miR&#x02010;297c&#x02010;5p regulated the process of myelin regeneration by promoting cell cycle arrest and differentiation of OPCs [<xref rid="cns70367-bib-0062" ref-type="bibr">62</xref>]. This study provides new ideas and possible therapeutic targets for miRNA&#x02010;based nerve repair therapy. The role of other miRNAs in BBB protection and their potential crosstalk with various signaling pathways, including NF&#x02010;&#x003ba;B [<xref rid="cns70367-bib-0056" ref-type="bibr">56</xref>], JAK/STAT [<xref rid="cns70367-bib-0057" ref-type="bibr">57</xref>], TGF&#x02010;&#x003b2;/Smad [<xref rid="cns70367-bib-0058" ref-type="bibr">58</xref>], FasL/PTEN [<xref rid="cns70367-bib-0021" ref-type="bibr">21</xref>], etc., warrants further investigation. In addition, it was demonstrated that miR&#x02010;297c&#x02010;5p antagomir reversed the low scores in the assessment of neurological function and low expression of occludin in MCAO mice. But it remains unclear the effects of miR&#x02010;297c&#x02010;5p on OGD cells with or without treatment of LSZ. Future studies using multi&#x02010;omic approaches will be crucial for unraveling the complex mechanisms of LSZ in BBB protection and its broader therapeutic potential.</p><p>Caveolins, the major structural proteins required to form <ext-link xlink:href="https://www.sciencedirect.com/topics/neuroscience/caveola" ext-link-type="uri">caveolae</ext-link>, are mostly found in brain endothelial cells, where they regulate the permeability of the BBB [<xref rid="cns70367-bib-0063" ref-type="bibr">63</xref>]. Several animal models, including vasogenic edema [<xref rid="cns70367-bib-0064" ref-type="bibr">64</xref>], brain ischemia [<xref rid="cns70367-bib-0065" ref-type="bibr">65</xref>], and <ext-link xlink:href="https://www.sciencedirect.com/topics/neuroscience/spinal-cord-injury" ext-link-type="uri">spinal cord injury</ext-link> [<xref rid="cns70367-bib-0066" ref-type="bibr">66</xref>], indicate the increase in caveolin&#x02010;1 levels in the <ext-link xlink:href="https://www.sciencedirect.com/topics/neuroscience/endothelium" ext-link-type="uri">endothelium</ext-link> is accompanied by the BBB breakdown. In the present study, bioinformatics analysis predicted caveolin&#x02010;1 as a miR&#x02010;297c&#x02010;5p target, and this prediction was demonstrated to be invalid by the results of miR&#x02010;297c&#x02010;5p agomir and antagomir transfection in cell cultures, which were not in line with basic rules of miRNA&#x02013;target interaction. Thus, there may exist other combined effects of miR&#x02010;297c&#x02010;5p on caveolins' expression.</p><p>In summary, this pilot study provides a strong evidence that miR&#x02010;297c&#x02010;5p is involved in the regulation of LSZ on occludin in the model of the BBB&#x02010;related damage, enlightening further investigations on it.</p></sec><sec id="cns70367-sec-0033"><title>Author Contributions</title><p>F.W. formulated the research questions and hypotheses. S.G. designed the study. T.M. supervised the study. S.G. took charge of most of the experiments and data analysis. X.W. and T.C. provided assistance in conducting experiments. S.G. drafted the manuscript, and T.L. revised the manuscript. R.J. and P.Y. participated in manuscript revision, experiment performance, and writing of the response letter. All authors contributed to the manuscript.</p></sec><sec id="cns70367-sec-0034"><title>Ethics Statement</title><p>All animal experiments in this study and publication of this study were approved by Ningxia Medical University General Hospital's Animal Ethics Committee (KYLL&#x02010;2024&#x02010;0275).</p></sec><sec sec-type="COI-statement" id="cns70367-sec-0035"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec></body><back><sec sec-type="data-availability" id="cns70367-sec-0032"><title>Data Availability Statement</title><p>Data are available at <ext-link xlink:href="https://www.jianguoyun.com/p/DZY-AGMQuaiFChjtit8FIAA" ext-link-type="uri" specific-use="software is-supplemented-by">https://www.jianguoyun.com/p/DZY&#x02010;AGMQuaiFChjtit8FIAA</ext-link>.</p></sec><ref-list content-type="cited-references" id="cns70367-bibl-0001"><title>References</title><ref id="cns70367-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cns70367-cit-0001">
<string-name>
<given-names>H.</given-names>
<surname>Kadry</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Noorani</surname>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>Cucullo</surname>
</string-name>, &#x0201c;<article-title>A Blood&#x02010;Brain Barrier Overview on Structure, Function, Impairment, and Biomarkers of Integrity</article-title>,&#x0201d; <source>Fluids and Barriers of the CNS</source>
<volume>17</volume>, no. <issue>1</issue> (<year>2020</year>): <fpage>69</fpage>.<pub-id pub-id-type="pmid">33208141</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cns70367-cit-0002">
<string-name>
<given-names>Y.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Kimura&#x02010;Ohba</surname>
</string-name>, <string-name>
<given-names>J. F.</given-names>
<surname>Thompson</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Vascular Tight Junction Disruption and Angiogenesis in Spontaneously Hypertensive Rat With Neuroinflammatory White Matter Injury</article-title>,&#x0201d; <source>Neurobiology of Disease</source>
<volume>114</volume> (<year>2018</year>): <fpage>95</fpage>&#x02013;<lpage>110</lpage>.<pub-id pub-id-type="pmid">29486300</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cns70367-cit-0003">
<string-name>
<given-names>Q.</given-names>
<surname>Yuan</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Jiang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Fan</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Ma</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Lei</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Su</surname>
</string-name>, &#x0201c;<article-title>Fumonisin B(1) Induces Oxidative Stress and Breaks Barrier Functions in Pig Iliac Endothelium Cells</article-title>,&#x0201d; <source>Toxins</source>
<volume>11</volume>, no. <issue>7</issue> (<year>2019</year>): <elocation-id>387</elocation-id>.<pub-id pub-id-type="pmid">31269688</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cns70367-cit-0004">
<string-name>
<given-names>Y.</given-names>
<surname>Xue</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Wan</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Caveolin&#x02010;1 Accelerates Hypoxia&#x02010;Induced Endothelial Dysfunction in High&#x02010;Altitude Cerebral Edema</article-title>,&#x0201d; <source>Cell Communication and Signaling: CCS</source>
<volume>20</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>160</fpage>.<pub-id pub-id-type="pmid">36253854</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cns70367-cit-0005">
<string-name>
<given-names>Y.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Zhao</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Comparative Study of Extracellular Vesicles Derived From Mesenchymal Stem Cells and Brain Endothelial Cells Attenuating Blood&#x02010;Brain Barrier Permeability via Regulating Caveolin&#x02010;1&#x02010;Dependent ZO&#x02010;1 and Claudin&#x02010;5 Endocytosis in Acute Ischemic Stroke</article-title>,&#x0201d; <source>Journal of Nanobiotechnology</source>
<volume>21</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>70</fpage>.<pub-id pub-id-type="pmid">36855156</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cns70367-cit-0006">
<string-name>
<given-names>T.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Jiang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Shen</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Impacts of Exposure to Nanopolystyrene and/or Chrysene at Ambient Concentrations on Neurotoxicity in <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Siniperca chuatsi</italic>
</styled-content>
</article-title>,&#x0201d; <source>Chemosphere</source>
<volume>340</volume> (<year>2023</year>): <elocation-id>139830</elocation-id>.<pub-id pub-id-type="pmid">37597625</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="cns70367-cit-0007">
<string-name>
<given-names>D. M.</given-names>
<surname>Elimam</surname>
</string-name>, <string-name>
<given-names>W. M.</given-names>
<surname>Eldehna</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Salem</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Natural Inspired Ligustrazine&#x02010;Based SLC&#x02010;0111 Analogues as Novel Carbonic Anhydrase Inhibitors</article-title>,&#x0201d; <source>European Journal of Medicinal Chemistry</source>
<volume>228</volume> (<year>2022</year>): <elocation-id>114008</elocation-id>.<pub-id pub-id-type="pmid">34871842</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cns70367-cit-0008">
<string-name>
<given-names>B.</given-names>
<surname>Yu</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Ruan</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Liang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Synergic Effect of Tetramethylpyrazine Phosphate and Borneol for Protecting Against Ischemia Injury in Cortex and Hippocampus Regions by Modulating Apoptosis and Autophagy</article-title>,&#x0201d; <source>Journal of Molecular Neuroscience</source>
<volume>63</volume>, no. <issue>1</issue> (<year>2017</year>): <fpage>70</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="pmid">28779236</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cns70367-cit-0009">
<string-name>
<given-names>J.</given-names>
<surname>Marco&#x02010;Contelles</surname>
</string-name>, &#x0201c;<article-title>Recent Advances on Nitrones Design for Stroke Treatment</article-title>,&#x0201d; <source>Journal of Medicinal Chemistry</source>
<volume>63</volume>, no. <issue>22</issue> (<year>2020</year>): <fpage>13413</fpage>&#x02013;<lpage>13427</lpage>.<pub-id pub-id-type="pmid">32869989</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cns70367-cit-0010">
<string-name>
<given-names>L.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Yao</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Ligustrazine Exerts Neuroprotective Effects via circ_0008146/miR&#x02010;709/Cx3cr1 Axis to Inhibit Cell Apoptosis and Inflammation After Cerebral Ischemia/Reperfusion Injury</article-title>,&#x0201d; <source>Brain Research Bulletin</source>
<volume>190</volume> (<year>2022</year>): <fpage>244</fpage>&#x02013;<lpage>255</lpage>.<pub-id pub-id-type="pmid">36244580</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cns70367-cit-0011">
<string-name>
<given-names>H.</given-names>
<surname>Cao</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Cheng</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Xu</surname>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>Ge</surname>
</string-name>, &#x0201c;<article-title>The Effect of Umbilical Cord Mesenchymal Stem Cells Combined With Tetramethylpyrazine Therapy on Ischemic Brain Injury: A Histological Study</article-title>,&#x0201d; <source>Journal of Stroke and Cerebrovascular Diseases</source>
<volume>29</volume>, no. <issue>12</issue> (<year>2020</year>): <elocation-id>105298</elocation-id>.<pub-id pub-id-type="pmid">32992203</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cns70367-cit-0012">
<string-name>
<given-names>P.</given-names>
<surname>Gong</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Zou</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Tetramethylpyrazine Attenuates Blood&#x02010;Brain Barrier Disruption in Ischemia/Reperfusion Injury Through the JAK/STAT Signaling Pathway</article-title>,&#x0201d; <source>European Journal of Pharmacology</source>
<volume>854</volume> (<year>2019</year>): <fpage>289</fpage>&#x02013;<lpage>297</lpage>.<pub-id pub-id-type="pmid">31004602</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="cns70367-cit-0013">
<string-name>
<given-names>H.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Cao</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Zhao</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>circDNMT1 Promotes Malignant Progression of Gastric Cancer Through Targeting miR&#x02010;576&#x02010;3p/Hypoxia Inducible Factor&#x02010;1 Alpha Axis</article-title>,&#x0201d; <source>Frontiers in Oncology</source>
<volume>12</volume> (<year>2022</year>): <elocation-id>817192</elocation-id>.<pub-id pub-id-type="pmid">35712504</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="cns70367-cit-0014">
<string-name>
<given-names>R.</given-names>
<surname>Zhao</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Cao</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Li</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Glucose Starvation Suppresses Gastric Cancer Through Targeting miR&#x02010;216a&#x02010;5p/Farnesyl&#x02010;Diphosphate Farnesyltransferase 1 Axis</article-title>,&#x0201d; <source>Cancer Cell International</source>
<volume>21</volume>, no. <issue>1</issue> (<year>2021</year>): <fpage>704</fpage>.<pub-id pub-id-type="pmid">34953498</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="cns70367-cit-0015">
<string-name>
<given-names>Q.</given-names>
<surname>Guo</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Luo</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Regulatory Network and Potential Role of LINC00973&#x02010;miRNA&#x02010;mRNA ceRNA in the Progression of Non&#x02010;Small&#x02010;Cell Lung Cancer</article-title>,&#x0201d; <source>Frontiers in Immunology</source>
<volume>12</volume> (<year>2021</year>): <elocation-id>684807</elocation-id>, <pub-id pub-id-type="doi">10.3389/fimmu.2021.684807</pub-id>.<pub-id pub-id-type="pmid">34394080</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="cns70367-cit-0016">
<string-name>
<given-names>X.</given-names>
<surname>Zhao</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Xiao</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Li</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>miRNA&#x02010;21 May Serve as a Promising Noninvasive Marker of Glioma With a High Diagnostic Performance: A Pooled Analysis of 997 Patients</article-title>,&#x0201d; <source>Therapeutic Advances in Medical Oncology</source>
<volume>13</volume> (<year>2021</year>): <elocation-id>1758835920987650</elocation-id>.<pub-id pub-id-type="pmid">33613699</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="cns70367-cit-0017">
<string-name>
<given-names>L.</given-names>
<surname>Shi</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Li</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Decreased miR&#x02010;132 Plays a Crucial Role in Diabetic Encephalopathy by Regulating the GSK&#x02010;3beta/Tau Pathway</article-title>,&#x0201d; <source>Aging</source>
<volume>13</volume>, no. <issue>3</issue> (<year>2020</year>): <fpage>4590</fpage>&#x02013;<lpage>4604</lpage>.<pub-id pub-id-type="pmid">33406505</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="cns70367-cit-0018">
<string-name>
<given-names>R.</given-names>
<surname>Rupaimoole</surname>
</string-name> and <string-name>
<given-names>F. J.</given-names>
<surname>Slack</surname>
</string-name>, &#x0201c;<article-title>MicroRNA Therapeutics: Towards a New Era for the Management of Cancer and Other Diseases</article-title>,&#x0201d; <source>Nature Reviews. Drug Discovery</source>
<volume>16</volume>, no. <issue>3</issue> (<year>2017</year>): <fpage>203</fpage>&#x02013;<lpage>222</lpage>.<pub-id pub-id-type="pmid">28209991</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="cns70367-cit-0019">
<string-name>
<given-names>K.</given-names>
<surname>Saliminejad</surname>
</string-name>, <string-name>
<given-names>H. R.</given-names>
<surname>Khorram Khorshid</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Soleymani Fard</surname>
</string-name>, and <string-name>
<given-names>S. H.</given-names>
<surname>Ghaffari</surname>
</string-name>, &#x0201c;<article-title>An Overview of microRNAs: Biology, Functions, Therapeutics, and Analysis Methods</article-title>,&#x0201d; <source>Journal of Cellular Physiology</source>
<volume>234</volume>, no. <issue>5</issue> (<year>2019</year>): <fpage>5451</fpage>&#x02013;<lpage>5465</lpage>.<pub-id pub-id-type="pmid">30471116</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="cns70367-cit-0020">
<string-name>
<given-names>Y.</given-names>
<surname>Fan</surname>
</string-name> and <string-name>
<given-names>Y.</given-names>
<surname>Wu</surname>
</string-name>, &#x0201c;<article-title>Tetramethylpyrazine Alleviates Neural Apoptosis in Injured Spinal Cord via the Downregulation of miR&#x02010;214&#x02010;3p</article-title>,&#x0201d; <source>Biomedicine &#x00026; Pharmacotherapy</source>
<volume>94</volume> (<year>2017</year>): <fpage>827</fpage>&#x02013;<lpage>833</lpage>.<pub-id pub-id-type="pmid">28802236</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="cns70367-cit-0021">
<string-name>
<given-names>J. H.</given-names>
<surname>Huang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Cao</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Zeng</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Tetramethylpyrazine Enhances Functional Recovery After Contusion Spinal Cord Injury by Modulation of MicroRNA&#x02010;21, FasL, PDCD4 and PTEN Expression</article-title>,&#x0201d; <source>Brain Research</source>
<volume>1648</volume>, no. <issue>Pt A</issue> (<year>2016</year>): <fpage>35</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">27431939</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="cns70367-cit-0022">
<string-name>
<given-names>H.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Luo</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Tsoi</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Gu</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Qi</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Shen</surname>
</string-name>, &#x0201c;<article-title>Angong Niuhuang Wan Reduces Hemorrhagic Transformation and Mortality in Ischemic Stroke Rats With Delayed Thrombolysis: Involvement of Peroxynitrite&#x02010;Mediated MMP&#x02010;9 Activation</article-title>,&#x0201d; <source>Chinese Medicine</source>
<volume>17</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>51</fpage>.<pub-id pub-id-type="pmid">35477576</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="cns70367-cit-0023">
<string-name>
<given-names>L.</given-names>
<surname>Kong</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Chang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>mtDNA&#x02010;STING Axis Mediates Microglial Polarization via IRF3/NF&#x02010;kappaB Signaling After Ischemic Stroke</article-title>,&#x0201d; <source>Frontiers in Immunology</source>
<volume>13</volume> (<year>2022</year>): <elocation-id>860977</elocation-id>.<pub-id pub-id-type="pmid">35450066</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="cns70367-cit-0024">
<string-name>
<given-names>E. Z.</given-names>
<surname>Longa</surname>
</string-name>, <string-name>
<given-names>P. R.</given-names>
<surname>Weinstein</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Carlson</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Cummins</surname>
</string-name>, &#x0201c;<article-title>Reversible Middle Cerebral Artery Occlusion Without Craniectomy in Rats</article-title>,&#x0201d; <source>Stroke</source>
<volume>20</volume>, no. <issue>1</issue> (<year>1989</year>): <fpage>84</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">2643202</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="cns70367-cit-0025">
<string-name>
<given-names>S. Y.</given-names>
<surname>Guan</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>X. S.</given-names>
<surname>Wang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Anxiolytic Effects of Polydatin Through the Blockade of Neuroinflammation in a Chronic Pain Mouse Model</article-title>,&#x0201d; <source>Molecular Pain</source>
<volume>16</volume> (<year>2020</year>): <elocation-id>1744806919900717</elocation-id>.<pub-id pub-id-type="pmid">31964240</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="cns70367-cit-0026">
<string-name>
<given-names>Y.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>X. L.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>H. B.</given-names>
<surname>Hu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Neuronal MeCP2 in the Dentate Gyrus Regulates Mossy Fiber Sprouting of Mice With Temporal Lobe Epilepsy</article-title>,&#x0201d; <source>Neurobiology of Disease</source>
<volume>188</volume> (<year>2023</year>): <elocation-id>106346</elocation-id>.<pub-id pub-id-type="pmid">37931884</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="cns70367-cit-0027">
<string-name>
<given-names>N.</given-names>
<surname>Azimi</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Yadollahikhales</surname>
</string-name>, <string-name>
<given-names>J. P.</given-names>
<surname>Argenti</surname>
</string-name>, and <string-name>
<given-names>M. G.</given-names>
<surname>Cunningham</surname>
</string-name>, &#x0201c;<article-title>Discrepancies in Stereotaxic Coordinate Publications and Improving Precision Using an Animal&#x02010;Specific Atlas</article-title>,&#x0201d; <source>Journal of Neuroscience Methods</source>
<volume>284</volume> (<year>2017</year>): <fpage>15</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">28392415</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="cns70367-cit-0028">
<string-name>
<given-names>K. A.</given-names>
<surname>Kim</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Kim</surname>
</string-name>, <string-name>
<given-names>J. H.</given-names>
<surname>Kim</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Autophagy&#x02010;Mediated Occludin Degradation Contributes to Blood&#x02010;Brain Barrier Disruption During Ischemia in bEnd.3 Brain Endothelial Cells and Rat Ischemic Stroke Models</article-title>,&#x0201d; <source>Fluids and Barriers of the CNS</source>
<volume>17</volume>, no. <issue>1</issue> (<year>2020</year>): <fpage>21</fpage>, <pub-id pub-id-type="doi">10.1186/s12987-020-00182-8</pub-id>.<pub-id pub-id-type="pmid">32169114</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="cns70367-cit-0029">
<string-name>
<given-names>S.</given-names>
<surname>Gong</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Ma</surname>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Zheng</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Inhibiting YAP in Endothelial Cells From Entering the Nucleus Attenuates Blood&#x02010;Brain Barrier Damage During Ischemia&#x02010;Reperfusion Injury</article-title>,&#x0201d; <source>Frontiers in Pharmacology</source>
<volume>12</volume> (<year>2021</year>): <elocation-id>777680</elocation-id>.<pub-id pub-id-type="pmid">34899341</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="cns70367-cit-0030">
<string-name>
<given-names>C.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>A. S.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Zhong</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Circular RNA AFF4 Modulates Osteogenic Differentiation in BM&#x02010;MSCs by Activating SMAD1/5 Pathway Through miR&#x02010;135a&#x02010;5p/FNDC5/Irisin Axis</article-title>,&#x0201d; <source>Cell Death &#x00026; Disease</source>
<volume>12</volume>, no. <issue>7</issue> (<year>2021</year>): <fpage>631</fpage>.<pub-id pub-id-type="pmid">34145212</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="cns70367-cit-0031">
<string-name>
<given-names>W.</given-names>
<surname>Liao</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Ruan</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Li</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Liu</surname>
</string-name>, &#x0201c;<article-title>Deciphering the Roles of Metformin in Alzheimer's Disease: A Snapshot</article-title>,&#x0201d; <source>Frontiers in Pharmacology</source>
<volume>12</volume> (<year>2021</year>): <elocation-id>728315</elocation-id>.<pub-id pub-id-type="pmid">35153733</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="cns70367-cit-0032">
<string-name>
<given-names>M. R.</given-names>
<surname>Du</surname>
</string-name>, <string-name>
<given-names>Q. Y.</given-names>
<surname>Gao</surname>
</string-name>, <string-name>
<given-names>C. L.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>L. Y.</given-names>
<surname>Bai</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Li</surname>
</string-name>, and <string-name>
<given-names>F. L.</given-names>
<surname>Wei</surname>
</string-name>, &#x0201c;<article-title>Exploring the Pharmacological Potential of Metformin for Neurodegenerative Diseases</article-title>,&#x0201d; <source>Frontiers in Aging Neuroscience</source>
<volume>14</volume> (<year>2022</year>): <elocation-id>838173</elocation-id>.<pub-id pub-id-type="pmid">35557834</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="cns70367-cit-0033">
<string-name>
<given-names>P.</given-names>
<surname>Ning</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Luo</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Mu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Xu</surname>
</string-name>, and <string-name>
<given-names>T.</given-names>
<surname>Li</surname>
</string-name>, &#x0201c;<article-title>Exploring the Dual Character of Metformin in Alzheimer's Disease</article-title>,&#x0201d; <source>Neuropharmacology</source>
<volume>207</volume> (<year>2022</year>): <elocation-id>108966</elocation-id>.<pub-id pub-id-type="pmid">35077762</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="cns70367-cit-0034">
<string-name>
<given-names>T.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Bai</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Liu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Novel Synergistic Mechanism of 11&#x02010;Keto&#x02010;Beta&#x02010;Boswellic Acid and Z&#x02010;Guggulsterone on Ischemic Stroke Revealed by Single&#x02010;Cell Transcriptomics</article-title>,&#x0201d; <source>Pharmacological Research</source>
<volume>193</volume> (<year>2023</year>): <elocation-id>106803</elocation-id>.<pub-id pub-id-type="pmid">37230158</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="cns70367-cit-0035">
<string-name>
<given-names>Z.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Lin</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Chen</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Autophagy Alleviates Hypoxia&#x02010;Induced Blood&#x02010;Brain Barrier Injury via Regulation of CLDN5 (Claudin 5)</article-title>,&#x0201d; <source>Autophagy</source>
<volume>17</volume>, no. <issue>10</issue> (<year>2021</year>): <fpage>3048</fpage>&#x02013;<lpage>3067</lpage>.<pub-id pub-id-type="pmid">33280500</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="cns70367-cit-0036">
<string-name>
<given-names>K. W.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>Z. W.</given-names>
<surname>Kou</surname>
</string-name>, <string-name>
<given-names>J. L.</given-names>
<surname>Mo</surname>
</string-name>, <string-name>
<given-names>X. X.</given-names>
<surname>Deng</surname>
</string-name>, and <string-name>
<given-names>F. Y.</given-names>
<surname>Sun</surname>
</string-name>, &#x0201c;<article-title>Neurovascular Coupling Protects Neurons Against Hypoxic Injury via Inhibition of Potassium Currents by Generation of Nitric Oxide in Direct Neuron and Endothelium Cocultures</article-title>,&#x0201d; <source>Neuroscience</source>
<volume>334</volume> (<year>2016</year>): <fpage>275</fpage>&#x02013;<lpage>282</lpage>.<pub-id pub-id-type="pmid">27531855</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="cns70367-cit-0037">
<string-name>
<given-names>A. R.</given-names>
<surname>Calabria</surname>
</string-name> and <string-name>
<given-names>E. V.</given-names>
<surname>Shusta</surname>
</string-name>, &#x0201c;<article-title>A Genomic Comparison of In&#x000a0;Vivo and In&#x000a0;Vitro Brain Microvascular Endothelial Cells</article-title>,&#x0201d; <source>Journal of Cerebral Blood Flow and Metabolism</source>
<volume>28</volume>, no. <issue>1</issue> (<year>2008</year>): <fpage>135</fpage>&#x02013;<lpage>148</lpage>.<pub-id pub-id-type="pmid">17565361</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="cns70367-cit-0038">
<string-name>
<given-names>M.</given-names>
<surname>De Bock</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Van Haver</surname>
</string-name>, <string-name>
<given-names>R. E.</given-names>
<surname>Vandenbroucke</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Decrock</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Wang</surname>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>Leybaert</surname>
</string-name>, &#x0201c;<article-title>Into Rather Unexplored Terrain&#x02010;Transcellular Transport Across the Blood&#x02010;Brain Barrier</article-title>,&#x0201d; <source>Glia</source>
<volume>64</volume>, no. <issue>7</issue> (<year>2016</year>): <fpage>1097</fpage>&#x02013;<lpage>1123</lpage>.<pub-id pub-id-type="pmid">26852907</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="cns70367-cit-0039">
<string-name>
<given-names>R. M.</given-names>
<surname>Linville</surname>
</string-name>, <string-name>
<given-names>M. B.</given-names>
<surname>Sklar</surname>
</string-name>, <string-name>
<given-names>G. N.</given-names>
<surname>Grifno</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Three&#x02010;Dimensional Microenvironment Regulates Gene Expression, Function, and Tight Junction Dynamics of iPSC&#x02010;Derived Blood&#x02010;Brain Barrier Microvessels</article-title>,&#x0201d; <source>Fluids and Barriers of the CNS</source>
<volume>19</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>87</fpage>.<pub-id pub-id-type="pmid">36333694</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="cns70367-cit-0040">
<string-name>
<given-names>J.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Hu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>FGF20 Protected Against BBB Disruption After Traumatic Brain Injury by Upregulating Junction Protein Expression and Inhibiting the Inflammatory Response</article-title>,&#x0201d; <source>Frontiers in Pharmacology</source>
<volume>11</volume> (<year>2020</year>): <elocation-id>590669</elocation-id>, <pub-id pub-id-type="doi">10.3389/fphar.2020.590669</pub-id>.<pub-id pub-id-type="pmid">33568994</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="cns70367-cit-0041">
<string-name>
<given-names>Y.</given-names>
<surname>Guo</surname>
</string-name>, <string-name>
<given-names>J. H.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>He</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Protocatechuic Aldehyde Prevents Ischemic Injury by Attenuating Brain Microvascular Endothelial Cell Pyroptosis via lncRNA Xist</article-title>,&#x0201d; <source>Phytomedicine</source>
<volume>94</volume> (<year>2022</year>): <elocation-id>153849</elocation-id>.<pub-id pub-id-type="pmid">34775360</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="cns70367-cit-0042">
<string-name>
<given-names>X.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Luo</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Chen</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Neuroprotection of 1,2,4&#x02010;Triazole Derivative by Inhibiting Inflammation and Protecting BBB Integrity in Acute Ischemic Stroke</article-title>,&#x0201d; <source>CNS Neuroscience &#x00026; Therapeutics</source>
<volume>30</volume>, no. <issue>11</issue> (<year>2024</year>): <elocation-id>e70113</elocation-id>.<pub-id pub-id-type="pmid">39500736</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="cns70367-cit-0043">
<string-name>
<given-names>A.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Zhu</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Qian</surname>
</string-name>, and <string-name>
<given-names>T.</given-names>
<surname>Zhu</surname>
</string-name>, &#x0201c;<article-title>Tetramethylpyrazine Reduces Blood&#x02010;Brain Barrier Permeability Associated With Enhancement of Peripheral Cholinergic Anti&#x02010;Inflammatory Effects for Treating Traumatic Brain Injury</article-title>,&#x0201d; <source>Experimental and Therapeutic Medicine</source>
<volume>14</volume>, no. <issue>3</issue> (<year>2017</year>): <fpage>2392</fpage>&#x02013;<lpage>2400</lpage>.<pub-id pub-id-type="pmid">28962173</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="cns70367-cit-0044">
<string-name>
<given-names>B.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Lu</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Bai</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Tetramethylpyrazine Identified by a Network Pharmacology Approach Ameliorates Methotrexate&#x02010;Induced Oxidative Organ Injury</article-title>,&#x0201d; <source>Journal of Ethnopharmacology</source>
<volume>175</volume> (<year>2015</year>): <fpage>638</fpage>&#x02013;<lpage>647</lpage>.<pub-id pub-id-type="pmid">26435225</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="cns70367-cit-0045">
<string-name>
<given-names>X.</given-names>
<surname>Feng</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Lin</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Tetramethylpyrazine Promotes Axonal Remodeling and Modulates Microglial Polarization via JAK2&#x02010;STAT1/3 and GSK3&#x02010;NFkappaB Pathways in Ischemic Stroke</article-title>,&#x0201d; <source>Neurochemistry International</source>
<volume>170</volume> (<year>2023</year>): <elocation-id>105607</elocation-id>.<pub-id pub-id-type="pmid">37657766</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="cns70367-cit-0046">
<string-name>
<given-names>Z.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Miao</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>The Protective Effects of Ligustrazine on Ischemic Stroke: A Systematic Review and Meta&#x02010;Analysis of Preclinical Evidence and Possible Mechanisms</article-title>,&#x0201d; <source>Frontiers in Pharmacology</source>
<volume>15</volume> (<year>2024</year>): <elocation-id>1373663</elocation-id>.<pub-id pub-id-type="pmid">38545549</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="cns70367-cit-0047">
<string-name>
<given-names>F.</given-names>
<surname>Feng</surname>
</string-name>, <string-name>
<given-names>D. Q.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>S. J.</given-names>
<surname>Yue</surname>
</string-name>, <string-name>
<given-names>Y. Y.</given-names>
<surname>Chen</surname>
</string-name>, and <string-name>
<given-names>Y. P.</given-names>
<surname>Tang</surname>
</string-name>, &#x0201c;<article-title>Neuroprotection by Tetramethylpyrazine and Its Synthesized Analogues for Central Nervous System Diseases: A Review</article-title>,&#x0201d; <source>Molecular Biology Reports</source>
<volume>51</volume>, no. <issue>1</issue> (<year>2024</year>): <fpage>159</fpage>.<pub-id pub-id-type="pmid">38252346</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="cns70367-cit-0048">
<string-name>
<given-names>Y.</given-names>
<surname>Rao</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Qiao</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Luo</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Liu</surname>
</string-name>, &#x0201c;<article-title>Synergistic Effects of Tetramethylpyrazine and Astragaloside IV on Spinal Cord Injury via Alteration of Astrocyte A1/A2 Polarization Through the Sirt1&#x02010;NF&#x02010;kappaB Pathway</article-title>,&#x0201d; <source>International Immunopharmacology</source>
<volume>131</volume> (<year>2024</year>): <elocation-id>111686</elocation-id>.<pub-id pub-id-type="pmid">38461631</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="cns70367-cit-0049">
<string-name>
<given-names>H.</given-names>
<surname>Jin</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>He</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Liu</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Ligustrazine Alleviates Spinal Cord Injury&#x02010;Induced Neuropathic Pain by Inhibiting the TLR4/NF&#x02010;kappaB Signaling Pathway</article-title>,&#x0201d; <source>American Journal of Translational Research</source>
<volume>16</volume>, no. <issue>8</issue> (<year>2024</year>): <fpage>3557</fpage>&#x02013;<lpage>3571</lpage>.<pub-id pub-id-type="pmid">39262708</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="cns70367-cit-0050">
<string-name>
<given-names>T.</given-names>
<surname>Zhao</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Fu</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Sun</surname>
</string-name>, and <string-name>
<given-names>X.</given-names>
<surname>Liu</surname>
</string-name>, &#x0201c;<article-title>Ligustrazine Suppresses Neuron Apoptosis via the Bax/Bcl&#x02010;2 and Caspase&#x02010;3 Pathway in PC12 Cells and in Rats With Vascular Dementia</article-title>,&#x0201d; <source>IUBMB Life</source>
<volume>70</volume>, no. <issue>1</issue> (<year>2018</year>): <fpage>60</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">29247598</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="cns70367-cit-0051">
<string-name>
<given-names>S.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Cao</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Tetramethylpyrazine Attenuates Oxygen&#x02010;Glucose Deprivation&#x02010;Induced Neuronal Damage Through Inhibition of the HIF&#x02010;1alpha/BNIP3 Pathway: From Network Pharmacological Finding to Experimental Validation</article-title>,&#x0201d; <source>Current Pharmaceutical Design</source>
<volume>29</volume>, no. <issue>7</issue> (<year>2023</year>): <fpage>543</fpage>&#x02013;<lpage>554</lpage>.<pub-id pub-id-type="pmid">36790003</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="cns70367-cit-0052">
<string-name>
<given-names>S. M.</given-names>
<surname>Toor</surname>
</string-name>, <string-name>
<given-names>E. K.</given-names>
<surname>Aldous</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Parray</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Circulating MicroRNA Profiling Identifies Distinct MicroRNA Signatures in Acute Ischemic Stroke and Transient Ischemic Attack Patients</article-title>,&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>24</volume>, no. <issue>1</issue> (<year>2022</year>): <elocation-id>108</elocation-id>, <pub-id pub-id-type="doi">10.3390/ijms24010108</pub-id>.<pub-id pub-id-type="pmid">36613546</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="cns70367-cit-0053">
<string-name>
<given-names>X.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>M. H.</given-names>
<surname>Hamblin</surname>
</string-name>, and <string-name>
<given-names>K. J.</given-names>
<surname>Yin</surname>
</string-name>, &#x0201c;<article-title>Noncoding RNAs and Stroke</article-title>,&#x0201d; <source>Neuroscientist</source>
<volume>25</volume>, no. <issue>1</issue> (<year>2019</year>): <fpage>22</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">29637805</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="cns70367-cit-0054">
<string-name>
<given-names>H.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Pan</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Xie</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Implication of MicroRNA503 in Brain Endothelial Cell Function and Ischemic Stroke</article-title>,&#x0201d; <source>Translational Stroke Research</source>
<volume>11</volume>, no. <issue>5</issue> (<year>2020</year>): <fpage>1148</fpage>&#x02013;<lpage>1164</lpage>.<pub-id pub-id-type="pmid">32285355</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="cns70367-cit-0055">
<string-name>
<given-names>D. L.</given-names>
<surname>Bernstein</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Zuluaga&#x02010;Ramirez</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Gajghate</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>miR&#x02010;98 Reduces Endothelial Dysfunction by Protecting Blood&#x02010;Brain Barrier (BBB) and Improves Neurological Outcomes in Mouse Ischemia/Reperfusion Stroke Model</article-title>,&#x0201d; <source>Journal of Cerebral Blood Flow and Metabolism</source>
<volume>40</volume>, no. <issue>10</issue> (<year>2020</year>): <fpage>1953</fpage>&#x02013;<lpage>1965</lpage>.<pub-id pub-id-type="pmid">31601141</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="cns70367-cit-0056">
<string-name>
<given-names>D.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Cerutti</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Lopez&#x02010;Ramirez</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Brain Endothelial miR&#x02010;146a Negatively Modulates T&#x02010;Cell Adhesion Through Repressing Multiple Targets to Inhibit NF&#x02010;kappaB Activation</article-title>,&#x0201d; <source>Journal of Cerebral Blood Flow and Metabolism</source>
<volume>35</volume>, no. <issue>3</issue> (<year>2015</year>): <fpage>412</fpage>&#x02013;<lpage>423</lpage>.<pub-id pub-id-type="pmid">25515214</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="cns70367-cit-0057">
<string-name>
<given-names>K. R.</given-names>
<surname>Barker</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Lu</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Kim</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>miR&#x02010;155 Modifies Inflammation, Endothelial Activation and Blood&#x02010;Brain Barrier Dysfunction in Cerebral Malaria</article-title>,&#x0201d; <source>Molecular Medicine</source>
<volume>23</volume> (<year>2017</year>): <fpage>24</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">28182191</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="cns70367-cit-0058">
<string-name>
<given-names>J. L.</given-names>
<surname>Qiu</surname>
</string-name>, <string-name>
<given-names>G. F.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>Y. N.</given-names>
<surname>Chai</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Ligustrazine Attenuates Liver Fibrosis by Targeting miR&#x02010;145 Mediated Transforming Growth Factor&#x02010;Beta/Smad Signaling in an Animal Model of Biliary Atresia</article-title>,&#x0201d; <source>Journal of Pharmacology and Experimental Therapeutics</source>
<volume>381</volume>, no. <issue>3</issue> (<year>2022</year>): <fpage>257</fpage>&#x02013;<lpage>265</lpage>.<pub-id pub-id-type="pmid">35398813</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="cns70367-cit-0059">
<string-name>
<given-names>S. P.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>Y. A.</given-names>
<surname>Chang</surname>
</string-name>, <string-name>
<given-names>C. H.</given-names>
<surname>Chou</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Circulating microRNAs Associated With Reversible Cerebral Vasoconstriction Syndrome</article-title>,&#x0201d; <source>Annals of Neurology</source>
<volume>89</volume>, no. <issue>3</issue> (<year>2021</year>): <fpage>459</fpage>&#x02013;<lpage>473</lpage>, <pub-id pub-id-type="doi">10.1002/ana.25965</pub-id>.<pub-id pub-id-type="pmid">33314303</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="cns70367-cit-0060">
<string-name>
<given-names>B.</given-names>
<surname>Sabirzhanov</surname>
</string-name>, <string-name>
<given-names>A. I.</given-names>
<surname>Faden</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Aubrecht</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Henry</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Glaser</surname>
</string-name>, and <string-name>
<given-names>B. A.</given-names>
<surname>Stoica</surname>
</string-name>, &#x0201c;<article-title>MicroRNA&#x02010;711&#x02010;Induced Downregulation of Angiopoietin&#x02010;1 Mediates Neuronal Cell Death</article-title>,&#x0201d; <source>Journal of Neurotrauma</source>
<volume>35</volume>, no. <issue>20</issue> (<year>2018</year>): <fpage>2462</fpage>&#x02013;<lpage>2481</lpage>.<pub-id pub-id-type="pmid">29774773</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="cns70367-cit-0061">
<string-name>
<given-names>P.</given-names>
<surname>Sun</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>S. H.</given-names>
<surname>Hassan</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Endothelium&#x02010;Targeted Deletion of microRNA&#x02010;15a/16&#x02010;1 Promotes Poststroke Angiogenesis and Improves Long&#x02010;Term Neurological Recovery</article-title>,&#x0201d; <source>Circulation Research</source>
<volume>126</volume>, no. <issue>8</issue> (<year>2020</year>): <fpage>1040</fpage>&#x02013;<lpage>1057</lpage>.<pub-id pub-id-type="pmid">32131693</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="cns70367-cit-0062">
<string-name>
<given-names>N. J.</given-names>
<surname>Kuypers</surname>
</string-name>, <string-name>
<given-names>A. N.</given-names>
<surname>Bankston</surname>
</string-name>, <string-name>
<given-names>R. M.</given-names>
<surname>Howard</surname>
</string-name>, <string-name>
<given-names>J. E.</given-names>
<surname>Beare</surname>
</string-name>, and <string-name>
<given-names>S. R.</given-names>
<surname>Whittemore</surname>
</string-name>, &#x0201c;<article-title>Remyelinating Oligodendrocyte Precursor Cell miRNAs From the Sfmbt2 Cluster Promote Cell Cycle Arrest and Differentiation</article-title>,&#x0201d; <source>Journal of Neuroscience</source>
<volume>36</volume>, no. <issue>5</issue> (<year>2016</year>): <fpage>1698</fpage>&#x02013;<lpage>1710</lpage>.<pub-id pub-id-type="pmid">26843650</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="cns70367-cit-0063">
<string-name>
<given-names>J.</given-names>
<surname>Godinho&#x02010;Pereira</surname>
</string-name>, <string-name>
<given-names>A. R.</given-names>
<surname>Garcia</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Figueira</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Malho</surname>
</string-name>, and <string-name>
<given-names>M. A.</given-names>
<surname>Brito</surname>
</string-name>, &#x0201c;<article-title>Behind Brain Metastases Formation: Cellular and Molecular Alterations and Blood&#x02010;Brain Barrier Disruption</article-title>,&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>22</volume>, no. <issue>13</issue> (<year>2021</year>): <elocation-id>7057</elocation-id>.<pub-id pub-id-type="pmid">34209088</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="cns70367-cit-0064">
<string-name>
<given-names>S.</given-names>
<surname>Nag</surname>
</string-name>, <string-name>
<given-names>J. L.</given-names>
<surname>Manias</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Kapadia</surname>
</string-name>, and <string-name>
<given-names>D. J.</given-names>
<surname>Stewart</surname>
</string-name>, &#x0201c;<article-title>Molecular Changes Associated With the Protective Effects of Angiopoietin&#x02010;1 During Blood&#x02010;Brain Barrier Breakdown Post&#x02010;Injury</article-title>,&#x0201d; <source>Molecular Neurobiology</source>
<volume>54</volume>, no. <issue>6</issue> (<year>2017</year>): <fpage>4232</fpage>&#x02013;<lpage>4242</lpage>.<pub-id pub-id-type="pmid">27335031</pub-id>
</mixed-citation></ref><ref id="cns70367-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="cns70367-cit-0065">
<string-name>
<given-names>I.</given-names>
<surname>Filchenko</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Blochet</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Buscemi</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Price</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Badaut</surname>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>Hirt</surname>
</string-name>, &#x0201c;<article-title>Caveolin&#x02010;1 Regulates Perivascular Aquaporin&#x02010;4 Expression After Cerebral Ischemia</article-title>,&#x0201d; <source>Frontiers in Cell and Development Biology</source>
<volume>8</volume> (<year>2020</year>): <fpage>371</fpage>.</mixed-citation></ref><ref id="cns70367-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="cns70367-cit-0066">
<string-name>
<given-names>M. C.</given-names>
<surname>Yang</surname>
</string-name>, <string-name>
<given-names>H. Z.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>F. L.</given-names>
<surname>You</surname>
</string-name>, and <string-name>
<given-names>Y. F.</given-names>
<surname>Wang</surname>
</string-name>, &#x0201c;<article-title>The Molecular Mechanism and Effect of Cannabinoid&#x02010;2 Receptor Agonist on the Blood&#x02010;Spinal Cord Barrier Permeability Induced by Ischemia&#x02010;Reperfusion Injury</article-title>,&#x0201d; <source>Brain Research</source>
<volume>1636</volume> (<year>2016</year>): <fpage>81</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">26835555</pub-id>
</mixed-citation></ref></ref-list></back></article>